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 In the initial project, a one-pot tandem reaction sequence was developed for the 
preparation of 2,3-dihydro-4-(1H)-quinolinones by a Michael addition-SNAr reaction 
sequence.  The steric environment of the Michael terminus plays a vital role in 
controlling the outcome of the reaction.  Larger groups at this site reverse the Michael-
SNAr reaction sequence and prevent the cyclization frm occurring.  Various amines were 
also examined to understand the steric control in this process.  In the second project, we 
synthesized tetrahydrobenzo[b]azepine by tandem reduction Michael addition and 
reductive amination reaction.  The third project focused on the development of a new 
synthetic route to prepare heteroarotinoids containing a nitrogen atom in the saturated 
heterocycle fused to the core aromatic ring.  Heteroarotinoids exhibit significant 
anticancer activity with low toxicity toward normal cells.  They regulate growth, 
differentiation, and apoptosis of cancer cells by interaction with nuclear proteins called 
retinoid receptors.  By incorporating a nitrogen atom in the heteroarotinoid, the drug may 
exhibit increased activity, solubility and bioavailability.  In Chapters IV and V, we aimed 
to synthesize supramolecular structures of porphyrins and phenyl acetylenes.  Attempts 
were made to synthesize co-facial porphyrins and cyclized phenyl acetylenes that have 
central cavities capable of binding metals and small organic molecules.  Neither of these 
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STERIC EFFECTS IN THE SYNTHESIS OF 2,3-DIHYDRO-4-(1H)-
QUINOLINONES BY THE TANDEM MICHEAL-S NAr REACTION 
Introduction  
 Tandem, cascade, domino or multistep one-pot reactions involve a consecutive 
series of reactions in which several bonds are formed in sequence without isolating 
intermediates, changing reaction conditions, or adding reagents.  Tandem reactions are 
important in organic synthesis for forming complex molecules with high selectivity from 
a single acyclic precursor in a few steps.  Moreover, the development of this type of 
synthetic method can lead to a reduction in the number of undesired by-products and the 
quantity of solvents required in isolation and purification of intermediates using stepwise 
synthetic processes.1  
 The use of the tandem reactions has provided an efficient and productive synthetic 
method for the synthesis of 2,3-dihydro-4(1H)-quinolinones.  These compounds possess a 
variety of biological activities and can be used to treat cancer2 (1), central nervous system 
disorders3 (2), steroid receptor modulator problems4 (3), and inflammatory diseases such 
as asthma5 (4) as shown in Figure 1.1.  Also these compounds are useful synthetic 





Figure 1.1.  A biologically active 2,3-dihydroquinolinones. 
  
 Different methods have been reported for the synthesis of 2-aryl-2,3-dihydro-
4(1H)-quinolinones.  Generally, it has been synthesized by cycloisomerization of 
substituted 2´-aminochalcone derivatives8 in the presence of acid or base such as 
H3PO4,
9a montmorillonite,9b InCl3,
9c silica gel-supported TaBr5,
9d silica gel-supported 
NaHSO4,





Figure 1.2.  General synthetic methods of 2-aryl-2,3-dihydro-4(1H)-quinolinones. 
 Bunce and co-workers10 have synthesized the of 2-aryl-2,3-dihydro-4(1H)-
quinolinones by tandem reduction-Michael addition of nitroaromatic compounds or 
Michael addition-nucleophilic aromatic substitution (SNAr) in fluoroaromatic substrates.  
Reduction of nitroaromatic compounds has been done by catalytic hydrogenation or 
dissolving metal reduction using iron (Fe) in aceti acid or hydrochloric acid.11  The 
intermediate amino group undergoes Michael addition o an α,β-unsaturated carbonyl 
compound forming the heterocyclic compound as shown in Figure 1.3.  The other tandem 
reaction involves Michael addition and SNAr reaction.  This tandem process involves the 
addition of a primary amine to the electron deficient β-carbon of the enone to form a 
secondary amine, and then ring closure follows by nucleophilic aromatic substitution12 as 
shown in Figure 1.4.     
 
Figure 1.3.  Tandem reduction of a nitroaromatic compounds.  













Figure 1.4.  Tandem reaction involves Michael addition-SNAr reactions. 
 In this project, we have examined the effect of substituents at the enone terminus 
on Michael addition-SNAr reactions for the synthesis of 2-aryl-2,3-dihydro-4(1H)-
quinolinone derivatives.  For this study we reacted simple substrates, monomethylated 
and dimethylated at the β-carbon, benzylamine, hexylamine and isobutylamine.   
Results and Discussion 
 The required cyclization substrates were prepared by a two-step sequence.  The 
reaction of 2-fluorobenzaldehyde (11) and 2-fluoro-5-nitrobenzaldehyde (12) in THF at  
-78 ºC with vinylmagnesium bromides 13-14 afforded the allylic alcohols 15-18 in 86-
88% yields.13  Oxidation of the allylic alcohols 15-18 with manganese(IV) oxide14  
produced the corresponding ketones in 65-84% yields as hown in Figure 1.5 and Table 
1.1.   
 










 15  (88) 19  (65) 
NO2 H CH3 16  (86) 20  (68) 
H CH3 CH3 17  (81) 23  (84) 
NO2 CH3 CH3 18  (88) 24  (81) 
 
Table 1.1.  Yields of allylic alcohol and enone derivatives. 
 
 Addition of the primary amines to the monomethylated enones 19 and 20 in DMF 
at 50 ºC afforded the cyclized products 21a-c and 22a-c in high yields, as shown in 
Figure 1.6 and Table 1.2.  On the other hand, addition of amines to dimethylated enone 
23 afforded low yields of cyclized products and the major component was unreacted 
starting material 23 (Figure 1.7 and Table 1.3).  The low yields from dimethylated 
substrate 23 is due to steric hindrance at β-carbon and the weakly activated aromatic ring 
toward nucleophilic aromatic substitution reaction.  Also, there is no significant increase 
in the yields of the cyclized products upon increasing the reaction temperature.  
 






















 21c  (78) 
NO2 C6H5CH2 22a  (97) 
NO2 n-C6H13 22b  (98) 
NO2 i-C4H9 22c  (92) 
 
Table 1.2.  Major products of cyclized mono methylated substrates 19 and 20.  
 
 Introduction of a second electron-withdrawing group on the aromatic ring of the 
dimethylated substrate had a dramatic effect on the yield of cyclized product and the 
mechanism of the reaction at the Michael terminus.10  Cyclization of substrate 24 
afforded three products, including the target cyclized products 25c-30c, 1-(2-
alkylamino)-5-nitrophenyl)-3-methyl-2-buten-1-one drivatives (26a, 28a or 30a) and 
acetophenone derivatives (26b, 28b or 30b) as shown in Figure 1.7 and Table 1.3.   
 






X R Product (%)  
 a  b  c 








0 0  4 
26 NO2 32  1  66  






0  0 12 
28 NO2 19  3  69  






0  0 7 
30 NO2 18  7  70  
 
Table 1.3.  Major products of cyclized substrates 23 and 24.  
  
 Mechanistically the formation of 26a, 28a or 30a could arise from a direct SNAr 
reaction12 of the primary amine on the aromatic ring due to the relatively slow addition at 
the β-carbon of the enone.  Once this addition happens, steric interaction between the 
amine and the side chain at the β-carbon would cause rotation about the benzylic bond t  
give a product stabilized by six-centered H-bonding.  Further addition of excess amine to 
the electron deficient β-carbon would produce a secondary amine, which would fragment 
to form the acetophenone derivative (26b, 28b or 30b) via the enol 33.  The acetone 
imine 34, also formed in this process, would hydrolyze and be lost in the work-up.  This 











 A study to probe the steric and electronic factors important in the Michael- SNAr 
sequence to produce 2,3-dihydro-4(1H)-quinolinones has been performed.  Three amines 
(benzylamine, hexylamine and isobutylamine) have ben used for this study.  Substrates 
bearing a single methyl group at the Michael terminus gave excellent yields of the 
cyclized product.  Increasing the steric bulk at the Michael terminus with gem-dimethyl 
slows the addition to the side chain double bond anreverses the Michael- SNAr 
sequence.  Introduction of an electron withdrawing group to activate the aromatic ring 
improves the yield of the cyclization product.  Once addition to the aromatic ring occurs, 
steric interaction between the added amine and the side chain causes rotation about the 













 All solvents were distilled prior to use. Other reag nts were used as received from 
various vendors.  All reactions were run under dry nitrogen in oven-dried glassware.  1-
Propenylmagnesium bromide (0.5 M in tetrahydrofuran) was purchased from Aldrich 
Chemical Company.  Commercial anhydrous N,N-dimethylfomamide (DMF) was 
syringed into reactions as needed.  Reactions were monitored by TLC on hard layer silica 
gel GF plates (Analtech No. 21521) using UV detection.  Preparative separations were 
performed using one of the following methods: (1) PTLC on 20-cm x 20-cm silica gel GF 
plates (Analtech No. 02015) or (2) flash column chromatography on silica gel (Davisil®, 
grade 62, 60-200 mesh) containing UV-active phosphor (S rbent Technologies No. UV-
05).  In each case, band elution was monitored using a hand-held UV-lamp.  IR spectra 
were taken on thin films on NaCl disks.  1H-NMR and 13C-NMR spectra were measured 
in CDCl3 at 300 MHz and 75 MHz, respectively, and were referenced to internal 
(CH3)4Si;  coupling constants (J) are in Hz. 
Representative Grignard Addition Procedure: (±)-(E)- and (±)-(Z)-1-(2-
Fluorophenyl)-2-buten-1-ol (15).  The general procedure of Danishefsky and co-
workers13 was used.  A 250-mL, three-necked, round-bottomed flask, equipped with a 
magnetic stirrer, a septum, a reflux condenser and a itrogen inlet was charged with 2-
fluorobenzaldehyde (11) (1.86 g, 15.0 mmoles) in dry THF (75 mL).  The soluti n was 
cooled to -78 ºC and 1-propenylmagnesium bromide (13) (45 mL, 0.5 M, 22.5 mmol) in 
THF was added dropwise.  The reaction mixture was stirred for 3.5 h at -78 ºC and then 




ether.  The combined ether extracts were washed three times with water, once with 
saturated aqueous NaCl, dried (MgSO4), filtered, and concentrated under vacuum to give 
15 (2.19 g, 88%) as viscous yellow oil.  This product mixture (E-15 and Z-15) was used 
without further purification.  IR: 3347, 1616, 1242 cm-1; 1H-NMR: δ 7.49 (overlapping 
td, 1H, J = 7.4, 1.6 Hz), 7.24 (m, 1H), 7.14 (td, 1H, J = 7.4, 1.6 Hz), 7.01 (ddd, 1H, J = 
9.3, 1.4, 1.1 Hz), 5.83 and 5.63 (2d, 1H, J = 7.1, 0.5 Hz), 5.73 (m, 0.5H), 5.61 (m, 1.5H), 
2.18 (br s, 1H), 1.77 and 1.70 (2d, 3H, J = 5.4, 4.9 Hz); 13C-NMR: δ 159.9 (d, J = 246.2 
Hz), 132.1, 131.4, 130.6 (d, J = 13.2 Hz), 129.0 (d, J = 8.3 Hz), 128.4 (d, J = 8.3 Hz), 
127.6, 127.4 (d, J = 4.3 Hz), 126.9, 124.3 (d, J = 3.4 Hz), 115.3 (d, J = 21.8 Hz), 69.2 (d, 
J = 2.2 Hz), 64.1 (d, J = 3.4 Hz), 17.6, 13.2.            
 (±)-(E)- and (±)-(Z)-1-(2-Fluoro-5-nitrophenyl)-2-buten-1-ol (16).  This compound 
(1.81 g, 86%) was prepared from 12 (1.69 g, 10.0 mmol) and 1-propenylmagnesium 
bromide (13) (30 mL, 0.5 M, 15.0 mmol) and isolated as a viscous yellow oil.  This 
product was used without further purification.  IR: 3378, 1629, 1530, 1350, 1247 cm-1; 
1H-NMR: δ 8.49 and 8.46 (dd, 1H, J = 6.1, 2.7 Hz), 8.18 (m, 1H), 7.16 (t, 1H, J = 9.2 
Hz), 5.84 (m, 1H), 5.68 (m, 1H), 5.51 (m, 1H), 2.55 (br s, 1H), 1.82 (dm, 1.5 H, J = 6.8 
Hz), 1.72 (dd, 1.5H, J = 6.4, 0.8 Hz); 13C-NMR: δ 163.2 (d, J = 262.8 Hz), 163.1 (d, J = 
262.8 Hz), 144.8, 132.6 (d, J = 15.5 Hz), 132.4 (d, J = 15.5 Hz), 131.0, 130.2, 129.1, 
128.5, 124.7 (d, J = 3.7 Hz), 124.6 (d, J = 3.7 Hz), 123.6 (d, J = 6.6 Hz), 116.3 (d, J = 
25.0 Hz), 68.4, 63.3, 17.6, 13.2. 
(±)-1-(2-Fluorophenyl)-3-methyl-2-buten-1-ol (17).  This compound (2.19 g, 81%) was 
prepared from 2-fluorobenzaldehyde (11) (1.86 g, 15.0 mmoles) and 2-methyl-1-
propenylmagnesium bromide (14) (45 mL, 0.5 M, 22.5 mmol) in dry THF and isolated as 
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a yellow oil.  This product was used without furthe purification.  IR: 3353, 1618, 1224 
cm-1; 1H-NMR: δ 7.50 (td, 1H, J = 7.7, 1.6 Hz), 7.22 (m, 1H), 7.14 (td, 1H, J = 7.7, 1.1 
Hz), 7.01 (m, 1H), 5.73 (dd, 1H, J = 8.8, 3.3 Hz), 5.40 (dq, 1H, J = 8.8, 1.1 Hz), 1.95 (d, 
1H, J = 3.3 Hz), 1.80 (s, 3H), 1.74 (s, 3H); 13C-NMR: δ 159.9 (d, J = 245.9 Hz), 135.9, 
131.1 (d, J = 13.2 Hz), 128.7 (d, J = 8.0 Hz), 127.3 (d, J = 4.6 Hz), 126.2, 124.2 (d, J = 
3.4 Hz), 115.3 (d, J = 21.3 Hz), 65.4 (d, J = 3.1 Hz), 25.8, 18.2.  Anal. Calcd. for 
C11H13FO: C, 73.33; H, 7.22.  Found: C, 73.37; H, 7.24. 
(±)-1-(2-Fluoro-5-nitrophenyl)-3-methyl-2-buten-1-ol (18).  This compound (1.98 g, 
88%) was prepared from 12 (1.69 g, 10.0 mmol) and 2-methyl-1-propenylmagnesium 
bromide (14) (30 mL, 0.5 M, 15.0 mmol) and isolated as a viscous yellow oil.  This 
product was used without further purification.  IR: 3372, 1626, 1531, 1350, 1248 cm-1; 
1H-NMR: δ 8.49 (dd, 1H, J = 6.2, 2.9 Hz), 8.15 (ddd, 1H, J = 9.0, 4.3, 2.9 Hz), 7.15 (t, 
1H, J = 9.0 Hz), 5.77 (d, 1H, J = 9.0 Hz), 5.30 (d, 1H, J = 9.0 Hz), 2.13 (br s, 1H), 1.84 
(s, 3H), 1.76 (s, 3H); 13C-NMR: δ 163.1 (d, J = 257.7 Hz), 144.5, 137.7, 133.1 (d, J = 
14.7 Hz), 125.1, 124.5 (d, J = 10.3 Hz), 123.6 (d, J = 7.4 Hz), 116.3 (d, J = 24.2 Hz), 
64.7 (d, J = 2.9 Hz), 25.8, 18.2 (d, J = 1.5 Hz).  Anal. Calcd. for C11H12FNO3: C, 58.67; 
H, 5.33; N, 6.22.  Found: C, 58.72; H, 5.55; N, 6.18. 
Representative Oxidation Using Manganese(IV) oxide: (E)- and (Z)-1-(2-
Fluorophenyl)-2-buten-1-one (19).  A 250-mL, round-bottomed flask, equipped with a 
magnetic stirrer and a reflux condenser was charged with a solution of 15 (1.0 g, 6.02 
mmol) in dichloromethane (25 mL).  Manganese(IV) oxide (10 g) was added and the 
reaction mixture was stirred vigorously at 23 ºC for 4-8 h.  The reaction mixture was 
filtered through a plug of Celite®, washed thoroughly with dichloromethane, and the 
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solvent was concentrated.  The product was purified on a 40-cm x 2.0-cm silica gel 
column eluted with increasing concentrations of ether in hexanes to give two bands.  
Band 1 gave (Z)-19 (127 mg, 13%) as viscous yellow oil.  IR: 1669, 1614, 1215 cm-1; 1H-
NMR: δ 7.78 (td, 1H, J = 7.7, 1.6 Hz), 7.49 (m, 1H), 7.22 (t, 1H, J = 7.7 Hz), 7.11 (dd, 
1H, J = 11.0, 8.2 Hz), 6.75 (dq, 1H, J = 11.2, 1.6 Hz), 6.44 (dq, 1H, J = 11.2, 7.1 Hz), 
2,19 (dd, 3H, J = 7.1, 1.6 Hz); 13C-NMR: δ 189.8, 161.1 (d, J = 253.9 Hz), 144.5, 133.8 
(d, J = 8.9 Hz), 130.8 (d, J = 2.6 Hz), 128.2 (d, J = 6.0 Hz), 127.7 (d, J = 13.2 Hz), 124.4 
(d, J = 3.4 Hz), 116.5 (d, J = 23.5 Hz), 16.4.  Anal. Calcd. for C10H9FO: C, 73.17; H, 
5.49.  Found: C, 73.12; H, 5.51. 
 Band 2 gave (E)-19 (516 mg, 52%) as viscous yellow oil.  IR: 1667, 1619, 1215 
cm-1; 1H-NMR: δ 7.70 (td, 1H, J = 7.7, 1.6 Hz), 7.48 (m, 1H), 7.22 (t, 1H, J = 7.7 Hz), 
7.12 (dd, 1H, J = 11.0, 8.2 Hz), 6.99 (m, 1H), 6.76 (dq, 1H, J = 15.4, 1.1 Hz), 1.98 (dd, 
3H, J = 6.6, 1.1 Hz); 13C-NMR: δ 189.5, 160.9 (d, J = 253.1 Hz), 145.5, 135.5 (d, J = 8.6 
Hz), 131.1 (d, J = 5.7 Hz), 130.7 (d, J = 2.9 Hz), 127.0 (d, J = 13.5 Hz), 124.3 (d, J = 3.4 
Hz), 116.4 (d, J = 23.2 Hz), 18.5.  Anal. Calcd. for C10H9FO: C, 73.17; H, 5.49.  Found: 
C, 73.15; H, 5.47.     
 (E)- and (Z)-1-(2-Fluoro-5-nitrophenyl)-2-buten-1-one (20).  This compound (0.67 g, 
ca. 5:1 E:Z mixture, 68%) was prepared from 16 (1.00 g, 4.74 mmol) and manganese(IV) 
oxide (10.0 g) in dichloromethane (25 mL) and was isolated as a light yellow oil.  The 
product was purified on a 40-cm x 2.0-cm silica gelco umn eluted with increasing 
concentrations of ether in hexanes to give two bands.  Band 1 gave (Z)-20 (119 mg, 12%) 
as light yellow solid, mp 43-45 ºC.  IR: 1675, 1612, 532, 1355, 1246 cm-1; 1H-NMR: δ 
8.69 (dd, 1H, J = 6.0, 2.7 Hz), 8.38 (dt, 1H, J = 9.3, 3.8 Hz), 7.31 (t, 1H, J = 9.3 Hz), 6.74 
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(dq, 1H, J = 11.5, 1.6 Hz), 6.57 (dq, 1H, J = 11.5, 7.1 Hz), 2.24 (d, 3H, J = 7.1 Hz); 13C-
NMR: δ 186.8, 163.9 (d, J = 264.0 Hz), 147.5, 144.5, 128.7 (d, J = 10.9 Hz), 128.6 (d, 
obscured), 127.1 (d, J = 4.9 Hz), 126.8 (d, J = 6.3 Hz), 118.0 (d, J = 26.1 Hz), 16.7.  
Anal. Calcd. for C10H8FNO3: C, 57.42; H, 3.83; N, 6.70.  Found: C, 57.49; H, 3.86; N, 
6.64. 
 Band 2 gave (E)-20 (555 mg, 56%) as light yellow solid, mp 43-45 ºC.  IR: 1674, 
1623, 1532, 1350, 1246 cm-1; 1H-NMR: δ 8.60 (dd, 1H, J = 6.0, 2.7 Hz), 8.37 (ddd, 1H, J 
= 9.3, 3.8, 2.7 Hz), 7.32 (t, 1H, J = 9.3 Hz), 7.07 (m, 1H), 6.74 (dq, 1H, J = 15.4, 1.6 Hz), 
2.03 (dd, 3H, J = 7.1, 1.6 Hz); 13C-NMR: δ 186.8, 163.8 (d, J = 263.4 Hz), 148.0, 144.3, 
130.1 (d, J = 5.1 Hz), 128.5 (d, J = 10.9 Hz), 127.9 (d, J = 16.6 Hz), 126.9 (d, J = 4.9 
Hz), 117.9 (d, J = 25.8 Hz), 18.7.  Anal. Calcd. for C10H8FNO3: C, 57.42; H, 3.83; N, 
6.70.  Found: C, 57.46; H, 3.85; N, 6.65. 
1-(2-Fluorophenyl)-3-methyl-2-buten-1-one (23).  This compound (1.82 g, 84%) was 
prepared from 17 (2.19 g, 12.2 mmol) and manganese(IV) oxide (22 g) in 
dichloromethane (45 mL).  The product was purified on a 40-cm x 2.0-cm silica gel 
column eluted with increasing concentrations of ether in hexanes to give 23 as a yellow 
oil.  IR: 1666, 1614, 1228 cm-1; 1H-NMR: δ 7.74 (td, 1H, J = 7.7, 1.6 Hz), 7.44 (m, 1H), 
7.19 (td, 1H, J = 8.2, 1.1 Hz), 7.09 (dd, 1H, J = 10.4, 8.8 Hz), 6.64 (m, 1H), 2.25 (s, 3H), 
1.99 (s, 3H); 13C-NMR: δ 189.1, 160.8 (d, J = 252.8 Hz), 157.4, 133.3 (d, J = 8.9 Hz), 
130.7 (d, J = 2.6 Hz), 128.2 (d, J = 4.3 Hz), 124.4 (d, J = 4.9 Hz), 124.2 (d, J = 3.4 Hz), 
116.3 (d, J = 23.2 Hz), 28.0, 21.4.  Anal. Calcd. for C11H11FO: C, 74.16; H, 6.18.  Found: 




1-(2-Fluoro-5-nitrophenyl)-3-methyl-2-buten-1-one (24).  This compound (0.80 g, 
81%) was prepared from 18 (1.00 g, 4.39 mmol) and manganese(IV) oxide (10.0 g) in 
dichloromethane (25 mL).  The product was purified on a 20-cm x 2.0-cm silica gel 
column eluted with increasing concentrations of ether in hexanes to give 24 as a light 
yellow solid, mp 54-55 ºC.  IR: 1667, 1624, 1532, 1350, 1252 cm-1; 1H-NMR: δ 8.64 (dd, 
1H, J = 6.0, 2.7 Hz), 8.35 (ddd, 1H, J = 9.3, 3.8, 2.7 Hz), 7.29 (t, 1H, J = 9.3 Hz), 6.62 (q, 
1H, J = 1.1 Hz), 2.30 (s, 3H), 2.06 (s, 3H); 13C-NMR: δ 186.1, 163.9 (d, J = 263.4 Hz), 
161.1, 144.4, 129.4, 128.2 (d, J = 10.9 Hz), 127.0 (d, J = 5.2 Hz), 123.1 (d, J = 5.7 Hz), 
117.9 (d, J = 26.3 Hz), 28.3, 21.8.  Anal. Calcd. for C11H10FNO3: C, 59.19; H, 4.48; N, 
6.28.  Found: C, 59.22; H, 4.49; N, 6.25. 
Representative Procedure for the Tandem Michael-SNAr Reaction: (±)-1-Benzyl-
2,3-dihydro-2-methyl-4(1H)-quinolinone (21a).  A 50-mL, round-bottomed flask, 
equipped with a magnetic stirrer and a reflux condenser was charged with a solution of 
19 (66 mg, 0.4 mmol) in anhydrous DMF (3 mL).  To the reaction mixture was added 
benzylamine (51 mg, 0.052 mL, 0.40 mmol) and the solution was heated at 50 ºC for 24 
h.  The reaction mixture was cooled and added to saturated aqueous NaCl (25 mL) and 
extracted three times with ether.  The combined ether extracts were washed with water, 
saturated aqueous NaCl, dried (MgSO4) and concentrated under vacuum to afford a 
yellow oil.  The product was purified by PTLC plate using 50-70% ether in hexanes to 
afford 21a (78 mg, 80%) as a light yellow solid, mp 88-90 ºC. IR: 1673 cm-1; 1H-NMR: 
δ 7.90 (dd, 1H, J = 7.9, 1.7 Hz), 7.39-7.25 (complex, 6H), 6.66 (apparent t, 1H, J = 7.4 
Hz), 6.57 (d, 1H, J = 8.6 Hz), 4.69 (d, 1H, J = 16.6 Hz), 4.37 (d, 1H, J = 16.6 Hz), 3.83 
(m, 1H), 3.06 (dd, 1H, J = 16.0, 6.1 Hz), 2.55 (dd, 1H, J = 16.0, 3.3 Hz), 1.22 (d, 3H, J = 
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6.6 Hz); 13C-NMR: δ 193.3, 149.4, 137.7, 135.7, 128.8, 127.6, 127.4, 126.4, 119.2, 116.4, 
113.5, 54.7, 53.3, 44.3, 15.4; ms: m/z 160 (M+-C7H7).  Anal. Calc. for C17H17NO: C, 
81.27; H, 6.77; N, 5.58.  Found: C, 81.28; H, 6.77; N, 5.59.  The yield in this reaction 
was the same using the Z isomer of the starting enone. 
(±)-1-Hexyl-2,3-dihydro-2-methyl-4(1H)-quinolinone (21b).  This compound (0.84 g, 
86%) was prepared from 19 (66 mg, 0.4 mmol) and hexylamine (49 mg, 0.063 mL, 0.48 
mmol).  The product was purified by PTLC plate using 10% ether in hexanes to afford 
21b as a viscous yellow oil.  IR: 1674 cm-1; 1H-NMR: δ 7.86 (dd, 1H, J = 8.2, 1.7 Hz), 
7.35 (ddd, 1H, J = 8.8, 7.2, 1.7 Hz), 6.63 (d, 1H, J = 8.8 Hz), 6.62 (t, 1H, J = 7.2 Hz), 
3.72 (m, 1H), 3.49 (dt, 1H, J = 14.8, 7.2 Hz), 3.07 (dt, 1H, J = 15.0, 7.4 Hz), 2.93 (dd, 
1H, J = 15.8, 6.1 Hz), 2.47 (dd, 1H, J = 16.0, 3.1 Hz), 1.67 (quintet, 2H, J = 7.2 Hz), 
1.45-1.29 (complex, 6H), 1.16 (d, 3H, J = 6.6 Hz), 0.91 (distorted t, 3H, J = 6.8 Hz); 13C-
NMR: δ 193.2, 149.1, 135.6, 127.7, 118.6, 115.3, 112.6, 54.5, 49.6, 44.0, 31.6, 27.9, 
26.8, 22.6, 15.6, 14.0; ms: m/z 174 (M+-C5H11).  Anal. Calc. for C16H23NO: C, 78.37; H, 
9.39; N, 5.71.  Found: C, 78.41; H, 9.42; N, 5.67.   
(±)-2,3-Dihydro-1-isobutyl-2-methyl-4(1H)-quinolinone (21c).  This compound (68 
mg, 78%) was prepared from 19 (66 mg, 0.4 mmol) and isobutylamine (29 mg, 0.040 
mL, 0.48 mmol).  The product was purified by PTLC plate using 10% ether in hexanes to 
afford 21c as a viscous yellow oil.  IR: 1674 cm-1; 1H-NMR: δ 7.87 (dd, 1H, J = 7.8, 1.8 
Hz), 7,34 (ddd, 1H, J = 8.6, 7.0, 1.8 Hz), 6.63 (apparent t, 1H, J = 7.8 Hz), 6.59 (d, 1H, J
= 8.6 Hz), 3.70 (quintet of d, 1H, J = 6.6, 2.3 Hz), 3.44 (dd, 1H, J = 14.4, 5.1 Hz), 2.99 
(dd, 1H, J = 15.9, 6.1 Hz), 2.64 (dd, 1H, J = 14.4, 9.6 Hz), 2.48 (dd, 1H, J = 15.9, 2.3 
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 Hz), 2.04 (m, 1H), 1.13 (d, 3H, J = 6.6 Hz), 1.04 (d, 3H, J = 6.6 Hz), 0.99 (d, 3H, J = 6.8 
Hz); 13C-NMR: δ 193.2, 149.1, 135.6, 127.7, 118.6, 115.4, 112.7, 57.7, 55.5, 43.7, 27.3, 
20.4, 20.0, 14.6; ms: m/z 174 (M+-C3H7).  Anal. Calc. for C14H19NO: C, 77.42; H, 8.76; 
N, 6.45.  Found: C, 77.45; H, 8.78; N, 6.40.   
(±)-1-Benzyl-2,3-dihydro-2-methyl-6-nitro-4(1H)-quinolinone (22a).  This compound 
(115 mg, 97%) was prepared from 20 (84 mg, 0.4 mmol) and benzylamine (51 mg, 0.052 
mL, 0.48 mmol).  The product was purified by PTLC plate using 10% ether in hexanes to 
afford 22a as a light yellow solid, mp 118-120 ºC.  IR: 1688, 1506, 1317 cm-1; 1H-NMR: 
δ 8.75 (d, 1H, J = 2.7 Hz), 8.09 (dd, 1H, J = 9.3, 2.7 Hz), 7.44-7.26 (complex, 5H), 6.64 
(d, 1H, J = 9.3 Hz), 4.84 (d, 1H, J = 16.8 Hz), 4.55 (d, 1H, J = 16.8 Hz), 3.98 (quintet of 
d, 1H, J = 6.4, 2.7 Hz), 3.08 (dd, 1H, J = 15.9, 6.0 Hz), 2.64 (dd, 1H, J = 15.9, 2.7 Hz), 
1.28 (d, 3H, J = 6.9 Hz); 13C-NMR: δ 191.1, 152.5, 137.6, 135.7, 130.2, 129.1, 128.0, 
126.2, 124.5, 117.5, 113.4, 55.0, 53.6, 43.3, 16.2; ms: m/z 205 (M+-C7H7).  Anal. Calc. 
for C17H16N2O3: C, 68.92; H, 5.41; N, 9.46.  Found: C, 68.88; H, 5.42; N, 9.43.    
(±)-1-Hexyl-2,3-dihydro-2-methyl-6-nitro-4(1H)-quinolinone (22b).  This compound 
(114 mg, 98%) was prepared from 20 (84 mg, 0.4 mmol) and hexylamine (49 mg, 0.063 
mL, 0.48 mmol).  The product was purified by PTLC plate using 10% ether in hexanes to 
afford 22b as a viscous yellow oil.  IR: 1688, 1510, 1315 cm-1; 1H-NMR: δ 8.72 (d, 1H, J 
= 2.8 Hz), 8.17 (dd, 1H, J = 9.6, 2.8 Hz), 6.67 (d, 1H, J = 9.6 Hz), 3.88 (quintet of d, 1H, 
J = 6.6, 2.4 Hz), 3.63 (dt, 1H, J = 14.7, 7.2 Hz), 3.23 (dt, 1H, J = 14.7, 7.6 Hz), 2.98 (dd, 
1H, J = 16.0, 6.2 Hz), 2.59 (dd, 1H, J =16.0, 2.5 Hz), 1.73 (quintet, 2H, J = 7.4 Hz), 1.46-
1.32 (complex, 6H), 1.23 (d, 3H, J = 6.8 Hz), 0.91 (distorted t, 3H, J = 6.9 Hz); 13C- 
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NMR: δ 191.2, 152.0, 136.9, 130.2, 124.8, 117.0, 112.5, 54.9, 50.4, 43.2, 31.4, 27.8, 
26.6, 22.5, 16.2, 13.9; ms: m/z 219 (M+-C5H11).  Anal. Calc. for C16H22N2O3: C, 66.21; H, 
7.59; N, 9.66.  Found: C, 66.26; H, 7.62; N, 9.58.   
(±)-2,3-Dihydro-1-isobutyl-2-methyl-6-nitro-4(1H)-quinolinone (22c).  This 
compound (96 mg, 92%) was prepared from 20 (84 mg, 0.4 mmol) and isobutylamine (29 
mg, 0.40 mL, 0.48 mmol).  The product was purified by PTLC plate using 10% ether in 
hexanes to afford 22c as a light yellow solid, mp 120-121 ºC.  IR: 1687, 1511, 1316 cm-1; 
1H-NMR: δ 8.74 (d, 1H, J = 2.8 Hz), 8.16 (dd, 1H, J = 9.4, 2.8 Hz), 6.66 (d, 1H, J = 9.4 
Hz), 3.85 (quintet of d, 1H, J = 6.6, 2.1 Hz), 3.59 (dd, 1H, J = 14.5, 5.3 Hz), 3.01 (dd, 
1H, J = 16.0, 6.1 Hz), 2.84 (dd, 1H, J = 14.5, 9.6 Hz), 2.60 (dd, 1H, J =16.0, 2.0 Hz), 
2.10 (m, 1H), 1.20 (d, 3H, J = 6.8 Hz), 1.08 (d, 3H, J = 6.6 Hz), 1.04 (d, 3H, J = 6.6 Hz); 
13C-NMR: δ 191.1, 152.2, 137.0, 130.1, 124.9, 117.1, 112.7, 57.8, 55.7, 42.9, 27.5, 20.2, 
20.0, 15.5; ms: m/z 219 (M+-C3H7).  Anal. Calc. for C14H18N2O3: C, 64.12; H, 6.87; N, 
10.69.  Found: C, 64.15; H, 6.89; N, 10.64.    
1-Benzyl-2,3-dihydro-2,2-dimethyl-4(1H)-quinolinone (25c).  A 50-mL, round-
bottomed flask, equipped with a magnetic stirrer and  reflux condenser was charged with 
a solution of 23 (71 mg, 0.4. mmol) in anhydrous DMF (3 mL) and benzylamine (48 mg, 
0.48 mmol).  The solution was heated at 50 ºC for 48 h.  The reaction mixture was 
cooled, added to saturated aqueous NaCl (25 mL) and extracted three times with ether.  
The combined ether extracts were washed with water, saturated aqueous NaCl, dried 
(MgSO4) and concentrated under vacuum to afford a yellow oil.  The product was 
purified by PTLC plate using 10% ether in hexanes.  Band 1 gave recovered starting  
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material 23 (47 mg, 67%).  Band 2 gave compound 25c (4 mg, 4%) as a light yellow 
solid, mp 114-115 ºC.  IR: 1676, 1605, 1364 cm-1; 1H-NMR: δ 7.90 (dd, 1H, J = 7.7, 1.6 
Hz), 7.36 (d, 3H, J = 4.4 Hz), 7.27 (m, 3H), 6.70 (t, 1H, J = 7.7 Hz), 6.50 (d, 1H, J = 8.2 
Hz), 4.54 (s, 2H), 2.77 (s, 2H), 1.34 (s, 6H); 13C-NMR: δ 193.8, 150.7, 138.9, 135.7, 
128.8, 127.1, 127.0, 125.8, 119.5, 116.5, 114.3, 58.4, 51.8, 49.5, 29.7, 24.8; ms: m/z 250 
(M+-CH3).  Anal. Calc. for C18H19NO: C, 81.51; H, 7.17; N, 5.28.  Found: C, 81.45; H, 
7.15; N, 5.33.     
1-Hexyl-2,3-dihydro-2,2-dimethyl-4(1H)-quinolinone (27c).  The procedure was the 
same as for 25c.  The product was purified by PTLC plate using 10% ether in hexanes.  
Band 1 gave recovered staring material 23 (35 mg, 50%).  Band 2 gave compound 27c 
(12 mg, 12%) as a yellow oil.  IR: 1680, 1604, 1361 cm-1; 1H-NMR: δ 7.87 (dd, 1H, J = 
7.7 Hz), 7.38 (ddd, 1H, J = 8.8, 7.1, 1.6 Hz), 6.67 (t, 1H, J = 7.1 Hz), 6.66 (d, 1H, J = 8.4 
Hz), 3.24 (t, 2H, J = 7.7 Hz), 2.60 (s, 2H), 1.66 (m, 2H), 1.37 (m, 6H), 1.30 (s, 6H), 0.93 
(t, 3H, J = 6.6 Hz); 13C-NMR: δ 193.9, 150.4, 135.6, 127.4, 119.2, 115.6, 113.2, 57.9, 
51.8, 45.6, 31.6, 29.5, 26.7, 24.9, 22.7, 14.0; ms: /z 188 (M+-C5H11).  Anal. Calc. for 
C17H25NO: C, 78.76; H, 9.65; N, 5.41.  Found: C, 78.90; H, 9.67; N, 5.32.              
2,3-Dihydro-1-isobutyl-2,2-dimethyl-4(1H)-quinolinone (29c).  The procedure was the 
same as for 25c.  The product was purified by PTLC plate using 10% ether in hexanes.  
Band 1 gave recovered starting material 23 (33 mg, 44%).  Band 2 gave compound 29c (7 
mg, 7%) as a yellow oil.  IR: 1679, 1604, 1366 cm-1; 1H-NMR: δ 7.91 (dd, 1H, J = 7.7, 
1.6 Hz), 7.37 (ddd, 1H, J = 8.8, 7.1, 1.6 Hz), 6.71-6.68 (m, 2H), 3.04 (d, 2H J = 7.7 Hz), 
2.64 (s, 2H), 2.07 (nonet, 1H, J = 7.1 Hz), 1.28 (s, 6H), 1.02 (d, 3H, J = 6.6 Hz); 13C- 
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NMR: δ 194.0, 151.3, 135.4, 127.5, 120.0, 116.2, 114.4, 58.6, 52.2, 30.3, 27.7, 25.1, 
20.5; ms: m/z 188 (M+-C3H7).  Anal. Calc. for C15H21NO: C, 77.92; H, 9.09; N, 6.06.  
Found: C, 77.99; H, 9.12; N, 5.97.   
Cyclization of compound 24.  Using the procedure given for the preparation of benzyl-
2,3-dihydro-2,2-dimethyl-4(1H)-quinolinone (25c), a solution of 24 (89 mg, 0.40. mmol) 
and the amine (0.48 mmol) in 2.5 mL of dry DMF was heated at 50 ºC for 24 h.  Workup 
and purification by PTLC using 10-20% ether in hexanes showed three major bands. 
Benzylamine.  Band 1 gave 1-(2-benzylamino-5-nitrophenyl)-3-methyl-2-buten-1-one 
(26a) (41 mg, 34%) as a light yellow solid, mp 92-94 ºC.  IR: 3265, 1609, 1505, 1328 
cm-1; 1H-NMR: δ 10.1 (br s, 1H), 8.77 (d, 1H, J = 2.7 Hz), 8.13 (dd, 1H, J = 9.4, 2.7 Hz), 
7.42-7.28 (complex, 5H), 6.73 (s, 1H), 6.68 (d, 1H,J = 9.4 Hz), 4.55 (d, 2H, J = 5.5 Hz), 
2.13 (s, 3H), 2.05 (s, 3H); 13C-NMR: δ 193.9, 155.9, 154.9, 136.8, 135.6, 129.5, 129.1, 
128.9, 127.7, 127.0, 121.6, 117.4, 111.8, 47.0, 27.8, 21.1; ms: m/z 219 (M+-C7H7).  Anal. 
Calc. for C18H18N2O3: C, 69.68; H, 5.81; N, 9.03.  Found: C, 69.67; H, 5.80; N, 9.05.   
 Band 2 gave 2-benzylamino-5-nitroacetophenone (26b) (1 mg, 1%) as a light 
yellow solid, mp 85-88 ºC.  IR: 3282, 1648, 1504, 1328 cm-1; 1H-NMR: δ 10.0 (br s, 1H), 
8.76 (d, 1H, J = 2.7 Hz), 8.16 (dd, 1H, J = 9.3, 2.7 Hz), 7.42-7.27 (complex, 5H), 6.69 (d, 
1H, J = 9.3 Hz), 4.55 (d, 2H, J = 6.0 Hz), 2.69 (s, 3H); 13C-NMR: δ 200.6, 154.5, 136.6, 
130.0, 129.8, 129.0, 127.8, 127.0, 116.2, 112.0, 47.0, 29.7, 27.9; ms: m/z 179 (M+-C7H7).  
Anal. Calc. for C15H14N2O3: C, 66.67; H, 5.19; N, 10.37.  Found: C, 66.70; H, 5.21; N, 
10.32.   
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 Band 3 gave 1-benzyl-2,3-dihydro-2,2-dimethyl-6-nitro-4(1H)-quinolinone (26c) 
(80 mg, 66%) as a light yellow solid, mp 137-138 ºC.  IR: 1691, 1506, 1323 cm-1; 1H-
NMR: δ 8.77 (d, 1H, J = 2.7 Hz), 8.08 (dd, 1H, J = 9.4, 2.7 Hz), 7.44-7.26 (complex, 
5H), 6.57 (d, 1H, J = 9.4 Hz), 4.71 (s, 2H), 2.83 (s, 2H), 1.40 (s, 6H); 13C-NMR: δ 191.7, 
153.9, 137.9, 136.7, 130.1, 129.1, 127.6, 125.5, 124.0, 118.2, 114.4, 59.2, 51.1, 49.5, 25.1 
(2C); ms: m/z 295 (M+-CH3).  Anal. Calc. for C18H18N2O3: C, 69.68; H, 5.81; N, 9.03.  
Found: C, 69.72; H, 5.79; N, 9.01.   
Hexylamine.  Band 1 gave 1-(2-hexylamino-5-nitrophenyl)-3-methyl-2-buten-1-one 
(28a) (23 mg, 19%) as a yellow solid, mp 44-46 ºC.  IR: 3262, 1644, 1610, 1505, 1327 
cm-1; 1H-NMR: δ 9.72 (br s, 1H), 8.74 (d, 1H, J = 2.7 Hz), 8.18 (dd, 1H, J = 9.4, 2.7 Hz), 
6.69 (m, 2H), 3.30 (dt, 2H, J = 7.1, 5.5 Hz), 2.12 (d, 3H, J = 1.1 Hz), 2.04 (s, 3H), 1.73 
(quintet, 2H, J = 7.1 Hz), 1.50-1.22 (complex, 6H), 0.91 (distorted , 3H, J = 6.8 Hz); 
13C-NMR: δ 194.0, 155.2, 155.1, 135.0, 129.6, 129.4, 121.8, 117.1, 111.2, 43.4, 28.8, 
27.7, 26.7, 22.5, 21.0, 14.0; ms: m/z 233 (M+-C5H11).  Anal. Calc. for C17H24N2O3: C, 
67.11; H, 7.89; N, 9.21.  Found: C, 67.15; H, 7.93; N, 9.16.   
 Band 2 gave 2-hexylamino-5-nitroacetophenone (28b) (3 mg, 3%) as a yellow oil.  
IR: 3267, 1648, 1502, 1329 cm-1; 1H-NMR: δ 9.66 (br s, 1H), 8.73 (d, 1H, J = 2.7 Hz), 
8.20 (dd, 1H, J = 9.4, 2.7 Hz), 6.71 (d, 1H, J = 9.4 Hz), 3.30 (dt, 2H, J = 7.1, 5.5 Hz), 
2.67 (s, 3H), 1.72 (quintet, 2H, J = 7.1 Hz), 1.51-1.24 (complex, 6H), 0.91 (distorted , 
3H, J = 6.6 Hz); 13C-NMR: δ 200.4, 154.7, 135.0, 130.1, 130.0, 115.6, 111.5, 43.0, 31.4, 
28.7, 27.8, 26, 7, 22.5, 14.0; ms: m/z 193 (M+-C5H11).  Anal. Calc. for C14H20N2O3: C, 
63.64; H, 7.58; N, 10.61.  Found: C, 63.71; H, 7.62; N, 10.54.   
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 Band 3 gave 1-hexyl-2,3-dihydro-2,2-dimethyl-6-nitro-4(1H)-quinolinone (28c) 
(83 mg, 69%) as a yellow solid, mp 78-79 ºC.  IR: 169 , 1503, 1322 cm-1; 1H-NMR: δ 
8.74 (d, 1H, J = 2.8 Hz), 8.19 (dd, 1H, J = 9.4, 2.8 Hz), 6.70 (d, 1H, J = 9.4 Hz), 3.39 
(distorted t, 2H, J = 8.2 Hz), 2.68 (s, 2H), 1.71 (quintet, 2H, J = 7.7 Hz), 1.48-1.34 
(complex, 6H), 1.38 (s, 6H), 0.94 (distorted t, 3H, J = 6.8 Hz); 13C-NMR: δ 191.7, 153.3, 
137.2, 130.1, 124.4, 117.8, 113.2, 58.7, 51.5, 45.9, 31.4, 29.1, 26.6, 25.3 (2C), 22.6, 13.9; 
ms: m/z 289 (M+-CH3).  Anal. Calc. for C17H24N2O3: C, 67.11; H, 7.89; N, 9.21.  Found: 
C, 67.16; H, 7.92; N, 9.13.    
Isobutylamine.  Band 1 gave 1-(2-isobutylamino-5-nitrophenyl)-3-methyl-2-buten-1-one 
(30a) (20 mg, 18%) as a light yellow solid, mp 75-77 ºC. IR: 3258, 1643, 1610, 1506, 
1327 cm-1.; 1H-NMR: δ 9.85 (br s, 1H), 8.74 (d, 1H, J = 2.7 Hz), 8.17 (dd, 1H, J = 9.3, 
2.7 Hz), 6.70 (s, 1H), 6.68 (d, 1H, J = 9.3 Hz), 3.13 (t, 2H, J = 6.6 Hz), 2.12 (s, 3H), 2.04 
(s, 3H), 2.03 (septet, 1H, J = 6.6 Hz), 1.06 (d, 6H, J = 6.6 Hz); 13C-NMR: δ 194.1, 155.3, 
155.2, 134.9, 129.5, 129.5, 129.4, 121.8, 117.1, 11.2, 50.7, 28.0, 27.7, 21.0, 20.4 (2C); 
ms: m/z 233 (M+-C3H7).  Anal. Calc. for C15H20N2O3: C, 65.22; H, 7.25; N, 10.14.  
Found: C, 65.19; H, 7.23; N, 10.15.   
 Band 2 gave 2-isobutylamino-5-nitroacetophenone (30b) (7 mg, 7%) as a yellow 
oil.  IR: 3272, 1652, 1509, 1328 cm-1; 1H-NMR: δ 9.78 (br s, 1H), 8.74 (d, 1H, J = 2.7 
Hz), 8.20 (dd, 1H, J = 9.4, 2.7 Hz), 6.70 (d, 1H, J = 9.4 Hz), 3.13 (t, 2H, J = 6.6 Hz), 2.67 
(s, 3H), 2.01 (septet, 1H, J = 6.6 Hz), 1.05 (d, 6H, J = 7.0 Hz); 13C-NMR: δ 200.5, 154.9, 
135.0, 130.1, 130.0, 115.7, 111.5, 50.7, 28.0, 27.8, 20.3 (2C); ms: m/z 193 (M+-C3H7).  
Anal. Calc. for C12H16N2O3: C, 61.02; H, 6.78; N, 11.86.  Found: C, 61.11; H, 6.81; N, 
11.78.    
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 Band 3 gave 1-isobutyl-2,3-dihydro-2,2-dimethyl-6-nitro-4(1H)-quinolione (30c) 
(77 mg, 70%) as a yellow solid, mp 126-127 ºC.  IR:1690, 1506, 1322 cm-1; 1H-NMR: δ 
8.70 (s, 1H), 8.17 (dd, 1H, J = 9.3, 2.7 Hz), 6.79 (d, 1H, J = 9.3 Hz), 3.24 (d, 2H, J = 7.7 
Hz), 2.71 (s, 2H), 2.12 (septet, 1H, J = 6.6 Hz), 1.37 (s, 6H), 1.05 (d, 6H, J = 6.6 Hz); 
13C-NMR: δ 191.8, 154.3, 137.5, 129.7, 124.4, 118.5, 114.5, 59.3, 52.2, 51.3, 28.0, 25.3 
(br, 2C), 20.3 (2C); ms: m/z 233 (M+-C3H7).  Anal. Calc. for C15H20N2O3: C, 65.22; H, 
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SYNTHESIS OF 2,3,4,5-TETRAHYDRO-1H-BENZO[b]AZEPINE  
Introduction  
 The heterocyclic ring of tetrahydrobenzazepine is found in many compounds that 
have biological activities for the treatment of disea es.  For example tetrahydro- 
benzo[d]azepine 1 (Figure 1.1) inhibits the squalene synthase enzyme.1  This enzyme is 
essential for the biosynthesis of cholesterol in humans and animals.2  
Tetrahydrobenzazepins that inhibit squalene synthase might be used for the treatment 
and/or prevention of cardiovascular disorders such as arteriosclerosis and 
dyslipidaemias.1  
 
Figure 2.1.  Biologically active tetrahydrobenzazepines.      
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 The teterahydrobenzo[b]azepine 2 stimulates the vasopressin V2 receptor in the 
kidney.3  Stimulation of this receptor reduces the volume of urine and, thus, these 
derivatives may be used in cases where a reduction of urine output is desired such as in 
enuresis.  Compound 3 inhibits the neuronal nitric oxide synthase (nNOS) enzyme.4  
Neuronal nitric oxide is important to brain development and memory, and its 
overproduction causes a variety of diseases such as Alzheimer`s disease and other 
neurodegenerative diseases.  Inhibitors of nNOS might also be used for the treatment of 
Parkinson’s and Alzheimer’s disease.5  
Synthesis of Tetrahydrobenzo[b]azepines 
 Different methods have been employed for the synthesis of 
tetrahydrobenzo[b]azepines.  Zhang and co-workers6 reacted tetralone (4) with 
hydroxylamine to generate oxime 5.  Enlarging of the ring was accomplished by addition 
of polyphosphoric acid (Beckmann rearrangement), followed by reduction with lithium 
aluminium hydride (LiAlH4) to obtain the target 2,3,4,5-tetrahydro-1H benzo[b]azepine 
(6) as shown in Figure 2.2.   
 
 
Figure 2.2.  Synthesis of tetrahydobenzo[b]azepine 6.  
 Hegedus and co-workers7 used palladium(II) as a catalyst for the cyclization of 
aniline derivative 7 for the preparation of the tetrahydrobenzo[b]azepine 8 (Figure 2.3).  
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The mechanism for the formation of the heterocyclic ompound involves nucleophilic 
attack of the amino group on the palladium(II)-olefin complex followed by 
hydrogenation.  Meyers and co-workers8 synthesized compound 8 by metalation of C-2 
in 9 with tert-butyllithium and alkylation of the lithio species 10 with methyl iodide 
followed by deprotection of the amino group with acid as shown in Figure 2.4.   
  
 
Figure 2.3.  Intramolecular cyclization of 2-(1,4-pentdienyl) aniline.  
 
 
Figure 2.4.  Meyers method for the synthesis of 8.    
 
 Tufariello and co-workers9 reported the preparation of aryl 
tetrahydobenzo[b]azepine 12 (Figure 2.5) by two different methods.  The first i  by 
oxidation of tetrahydrobenzo[b]azepine (6) to the corresponding nitrone derivative 11
with m-chloroperoxybenzoic acid.10  Addition of phenylmagnesium bromide to the 
nitrone11 11 afforded 12 and 13.  The hydroxylamine derivative 13 was converted to 12 





Figure 2.5.  Synthesis of 12 by oxidation and Grignard addition to the nitrone.  
 
 
Figure 2.6.  Hydrogenolysis of N-hydroxytetrahydrobenzo[b]azepine 11. 
  
 The second method involved heating of C,N-diphenylnitrone 14 with excess 
allene (15) in a sealed tube at 70 ºC for 60 h.  Three adducts were isolated: the 
isoxazolidine 17 (22%), the 3-pyrroldinone 18 (23%) and the 
tetrahydrobenzo[b]azepinone 21 (31%).  The latter was reduced under Wolf-Kishner 
conditions to afford 12 as shown in Figure 2.7.  The nitrogen-oxygen bond in 16 is 
relatively weak and readily cleaved.13 Additionally, in the presence of the N-aryl group, 
compound 16 undergoes spontaneous rearrangement to the tetrahydrobenzo[b]azepine 
20.9 
 Our approach to tetrahydrobenzo[b]azepines involves a tandem reduction-












































Figure 2.7.  Intermolecular allene-nitrone cycloaddition.  
 
Results and Discussion  
Synthesis of Phenyl Vinyl Ketone 
 The method of Reich et al.16 was used for the preparation of phenyl vinyl keton.  
Deprotonation of ketone 22 using lithium diisopropylamine (LDA) in dry THF produced 
the ketone enolate.  Nucleophilic substitution of this enolate with benzeneselenenyl 
bromide (23) formed the α-phenylselenoketone 24 (Figure 2.8).  Benzeneselenenyl 
bromide (23) was prepared by cleavage of diphenyldiselenide withbromine.16  Oxidation 
of 24 using hydrogen peroxide at 30-35 ºC afforded the targe  substrate 25.  This reaction 
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step involved oxidation of selenium and elimination of phenylseleninic acid (27) from 26 
to give 25 as shown in Figure 2.9.16 
 


















Figure 2.9.  Oxidation-elimination reaction for the formation of 25. 
Synthesis of Tetrahydrobenzo[b]azepines 
 The synthesis of tetrahydrobenzo[b]azepines 8 and 12 is shown in Figure 2.10.  
Bunce and co-workers14,15 have previously synthesized aryl-fused nitrogen heterocyclic 
compounds by a tandem reduction-reductive amination.  Reaction of methyl (2-
nitrophenyl)acetate (28) with K2CO3 in DMF generated the blue colored anion of 28,
which reacted with vinyl ketones 25 and 29 to form the ketones 30.  Basic hydrolysis of 
30 with aqueous NaOH (1 M) formed acid 31, which was decarboxylated to 32 using 
K2CO3 in DMF at 50 ºC.
17  The target tetrahydrobenzo[b]azepines 8 and 12 were formed 
by hydrogenation of 32 using two methods.  In method A, the reaction mixture containing 
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32 in methanol and 5% Pd/C as a catalyst was hydrogenated at 1 atm (balloon).  In 
method B, hydrogen gas was generated in situ upon addition of triethylsilane (TES) to the 
reaction mixture containing 32 in methanol and 5% Pd/C.18  A low yield was obtained 
from method A due to the lack of pressure during hydrogenation.  Method B gave 




















30a R = CH3 98%
30b R = Ph 89%
31a R = CH3 97%






32a R = CH3 93%
32b R = Ph 54%
Pd/C 5%, H2
Pd/C 5%, TES
28 25 R = Ph
29 R = CH3
MeOH, rt
MeOH, rt
8 R = CH3








Product No R A B 
8 CH3 29% 59% 
12 Ph 17% 48% 
 
Table 2.1.  Yield of reductive amination reaction to form 8 and 12. 
    Alkylation of the blue-colored anion of methyl (2-nitrophenyl)acetate (28) with 
4-bromobutene derivatives 33a and 33b using K2CO3 and catalytic 18-crown-6 in DMF 
and stirring at room temperature afforded 34a-b.14  Basic hydrolysis of 34a-b with KOH 
in THF formed acids 35a-b,17 which were decarboxylated to produce 36a-b as shown in 
Figure 2.11.   
 
Figure 2.11.  Synthesis of the cyclization substrates. 
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 Treatment of 36a with ozone in methanol at -78 ºC followed by reduction of the 
ozonide intermediate with dimethyl sulfide produced the aldehyde 37 (Figure 2.12).14 
Treatmet of aldehyde 37 with methyl triphenylphosphoranylidene acetate (38) in benzene 
and heating the reaction mixture formed the E isomer of the alkene 39 in 95% yield along 
with 3-5% of the Z isomer.  Ring closure of the E substrate was accomplished by tandem 
reduction-Michael addition reactions using iron in acetic acid to produce 40 (83%) as 
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Figure 2.12.  Ozonolysis, Wittig reaction and reductive amination f r the synthesis of 40.   
 A Horner-Wadsworth-Emmons reaction of 32a using ethyl 2-
(dimethoxyphosphoryl)acetate (41) in the presence of NaH in THF with stirring at room 
temperature produced the isomeric mixture of (E) and (Z) 42.20  Cyclization of this 
mixture by reduction of nitro group with Fe/AcOH, followed by a Michael addition 




Figure 2.13.  Horner-Wadsworth-Emmons reaction and reductive amintio  for the 














 We have developed a synthetic method for the preparation of 2,3,4,5-tetrahydro-
1H-benzo[b]azepine derivatives by tandem reduction-reductive amination. Substrates for 
this reaction were prepared in excellent yield by a Michael addition reaction of vinyl 
ketone derivatives to compound 28, followed by basic hydrolysis with potassium 
hydroxide and decarboxylation using K2CO3 in DMF.  We were also able to prepare 
2,3,4,5-tetrahydro-1H-benzo[b]azepine derivatives by a tandem reduction-Michael 
addition of substrates prepared by alkylation of the substrate 28 with 4-bromobutene, 
followed by ozone treatment and Wittig olefination.  Most reaction targets were obtained 
in high yields.  The cyclized products were isolated in moderate yields, which might be 
improved by using catalytic hydrogenation under pressure. 












 THF was distilled prior to use.  All other commercial reagents and solvents were 
used as received.  All reactions were run under dry nitrogen in oven-dried glassware.  
Potassium carbonate was ground to a fine powder, dri d under vacuum at 120 °C for 24 h 
and stored in an oven at 120 °C.  Commercial anhydrous N,N-dimethylfomamide (DMF) 
was syringed into reactions as needed.  Reactions were monitored by TLC on hard layer 
silica gel GF plates (Analtech No. 21521) using UV detection.  Preparative separations 
were performed using one of the following methods: (1) PTLC on 20-cm x 20-cm silica 
gel GF plates (Analtech No. 02015) or (2) flash column chromatography on silica gel 
(Davisil®, grade 62, 60-200 mesh) containing UV-active phospr (Sorbent Technologies 
No. UV-05).  In each case, band elution was monitored using a hand-held UV-lamp.  IR 
spectra were run as thin films on NaCl disks.  1H-NMR and 13C-NMR spectra were 
measured in CDCl3 at 300 MHz and 75 MHz, respectively, and were referenced to 
internal (CH3)4Si;  coupling constants (J) are in Hz. 
1-Phenyl-2-phenylseleno-1-propanone (24).  The method of Reich and co-workers16 
was followed.  A 250-mL, three-necked, round-bottomed flask, equipped with a magnetic 
stirrer, a septum and a 10-mL addition funnel was charged with freshly distilled THF (40 
mL).  The flask was cooled to -78 ºC, and diisopropylamine (130 g, 1.80 mL, 12.8 mmol) 
was added, followed by n-BuLi (6.0 mL, 2.5 M, 15.0 mmol) in hexane.  A solution of 
propiophenone (22) (1.34 g, 10.0 mmol) in 5 mL of THF was added dropwise, and the 
solution was stirred for 15 min.  Into the addition fu nel was placed diphenyl diselenide 
(1.88 g, 6.0 mmol) as a solution in 5 mL of THF.  Bromine (0.4 mL, 1.18 g, 7.4 mmol) 
was added dropwise to the solution, which was agitated briefly to dissolve any PhSeBr3 
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formed.  The PhSeBr solution was added rapidly to the enolate solution of 22 (immediate 
decolorization), and the cold reaction mixture was poured into HCl (100 mL, 0.5 M) and 
100 mL of ether.  The organic layer was washed withater, saturated NaHCO3 solution, 
saturated aqueous NaCl, dried (NaSO4), filtered, and concentrated.  The residue was 
chromatographed using 1-3% ether in hexanes to afford 24 (2.8 g, 96%).  1H NMR δ 
7.88-7.86 (m, 2H), 7.52-7.20 (m, 8H), 4.67 (q, 1H, J = 7.0 Hz), 1.61 (d, 3H, J = 7.0 Hz). 
1-Phenyl-2-propen-1-one (25).  The method of Reich and co-workers16 was followed.  
To a 250-mL, three-necked, round-bottomed flask, equipped with a dropping funnel, 
condenser, and thermometer was added a solution of 24 (1.0 g, 3.0 mmol) in 30 mL of 
dichloromethane containing 0.5 mL of pyridine.  To the stirred solution was gradually 
added H2O2 (4.0 mL, 30% H2O2 in 4 mL of water), with cooling by an ice-salt bath to 
keep the temperature between 30 and 35 ºC.  The reaction mixture was stirred vigorously 
at room temperature for an additional 15 min and then was added to 25 mL of 
dichloromethane and 10 mL of 7% NaHCO3 solution.  The aqueous layer was washed 
three times with dichloromethane (15 mL), and the combined extracts were washed with 
10% HC1 (30 mL), saturated aqueous NaCl, dried (Na2SO4), filtered, and concentrated to 
give 25 (0.3 g, 56%), which was used for next step without further purification.  1H NMR 
δ 7.93 (dd, 2H, J = 8.0, 2.0 Hz), 7.59-7.44 (m, 3 H), 7.20-7.11 (dd, 1H, J = 17.3, 10.7 
Hz), 6.44 (dd, 1H, J = 17.3, 2.2 Hz), 5.92 (dd, 1H, J = 10.7, 2.2 Hz).   
Methyl 2-(2-nitrophenyl)-5-oxohexanoate (30a).   A 100-mL, three-necked, round-
bottomed flask, equipped with a magnetic stirrer, and  reflux condenser was charged 
with 28 (1.00 g, 5.17 mmol) in dry DMF (25 mL), and 18-crown-6 (0.20 g) was added.  
To the stirred solution was added anhydrous potassium carbonate (2.5 g, 18.1 mmol).  
41 
 
The mixture turned blue in color and stirring was continued for 5 min.  Methyl vinyl 
ketone (29) (0.50 g, 0.6 mL, 7.13 mmol) was added dropwise, and the reaction mixture 
was stirred for 3 h.  Water (100 mL) was added, andthe product was extracted three 
times with ether (50 mL).  The ether extracts were washed with saturated aqueous NaCl, 
dried (MgSO4), filtered, and concentrated.  The residue was chromatographed using 10-
20% ether in hexane to afford 30a (1.33 g, 98%) as a yellow oil.  IR 1736, 1608, 1526, 
1335, 787 cm-1; 1H NMR δ 7.89 (dd, 1H, J = 8.2, 1.1 Hz), 7.61 (td, 1H, J = 8.2, 1.1 Hz), 
7.53-7.42 (m, 2H), 4.18 (t, 1H, J = 7.7 Hz), 3.66 (s, 3H), 2.63-2.40 (m, 3H), 2.12 (s, 3H), 
2.16-2.07 (m, 1H); 13C NMR δ 207.7, 173.0, 149.7, 133.5, 130.3, 128.7, 125.1, 52.6, 
45.5, 41.4, 30.2, 26.9.    
Methyl 2-(2-nitrophenyl)-5-oxo-5-phenylpentanoate (30b).  A 100-mL, three-necked, 
round-bottomed flask, equipped with a magnetic stirrer and a reflux condenser was 
charged with 28 (0.70 g, 3.61 mmol) in dry DMF (20 mL), and 18-crown-6 (0.20 g) was 
added.  To the stirred solution was added anhydrous p tassium carbonate (3.0 g, 21.7 
mmol).  The mixture turned blue in color and stirring was continued for 5 min.  Phenyl 
vinyl ketone (25) (0.80 g, 6.05 mmol) was added dropwise, and the reaction mixture was 
stirred for 3 h.  Water (100 mL) was added and the product was extracted three times 
with ether (50 mL).  The ether extracts were washed with saturated aqueous NaCl, dried 
(MgSO4), filtered, and concentrated.  The residue was chromatographed using 10-20% 
ether in hexane to afford 30b (1.04 g, 87%) as a light yellow oil.  IR 1736, 1686, 1527, 
1353, 744 cm-1; 1H NMR δ 7.93 7.88 (m, 3H), 7.60-7.53 (m, 3H), 7.46-7.41 (m, 3H), 
4.31 (t, 1H, J = 7.7 Hz), 3.67 (s, 3H), 3.18-2.95 (m, 2H), 2.70-2.58 (m, 1H), 2.35-2.23 
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(m, 1H); 13C NMR δ 199.2, 173.1, 137.0, 133.6, 133.5, 130.4, 129.0, 128.7, 128.4, 125.2, 
52.7, 45.8, 36.6, 27.5. 
2-(2-Nitrophenyl)-5-oxohexanoic acid (31a).  The general procedure of Bull et al.17 was 
followed.  A 100-mL, round-bottomed flask, equipped with a magnetic stirrer and a 
reflux condenser was charged with ester 30a (0.15 g, 0.46 mmol) in dioxane (15 mL).  
Aqueous sodium hydroxide (20 mL, 1 M) was added and the reaction mixture was stirred 
overnight at room temperature.  The solvent was evaporated, water (10 mL) was added 
and the mixture acidified with 1 M HCl.  The product was extracted three times with 
ether (10 mL), washed with saturated aqueous NaCl, dried (MgSO4), filtered, and 
concentrated.  The residue was chromatographed using 30% ether in hexanes to afford 
31a (0.14 g, 97%) as a yellow oil.  IR 1712, 1527, 1353, 787 cm-1; 1H NMR δ 11.00 (s, 
1H), 7.92 (dd, 1H, J = 8.8, 1.1 Hz), 7.60 (td, 1H, J = 7.1, 1.1 Hz), 7.52-7.42 (m, 2H), 4.19 
(t, 1H, J = 7.1 Hz), 2.62-2.42 (m, 3H), 2.17-2.04 (m, 1H), 2.11 (s, 3H); 13C NMR δ 208.6, 
178.0, 149.5, 133.8, 133.1, 130.7, 129.0, 125.3, 45.9, 41.4, 30.3, 26.4. 
2-(2-Nitrophenyl)-5-oxo-5-phenylpentanoic acid (31b).  The general procedure of Bull 
et al.17 was followed.  A 100-mL, round-bottomed flask, equipped with a magnetic stirrer 
and a reflux condenser was charged with ester 30b (0.15 g, 0.46 mmol) in dioxane (15 
mL).  Aqueous sodium hydroxide (20 mL, 1 M) was added and the reaction mixture was 
stirred overnight at room temperature.  The solvent was evaporated, water (10 mL) was 
added and the mixture acidified with 1 M HCl.  The product was extracted three times 
with ether (10 mL), washed with saturated aqueous NaCl, dried (MgSO4), filtered, and 
concentrated.  The residue was chromatographed using 30% ether in hexanes to afford  
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31b (0.11 g, 78%) as light brown oil.  IR 1709, 1685, 1 26, 1350, 738 cm-1; 1H NMR δ 
10.03 (s, 1H), 7.93-7.88 (m, 3H), 7.62-7.42 (m, 6H), 4.34 (t, 1H, J = 7.1 Hz), 3.16 (m, 
2H), 2.67-2.61 (m, 1H), 2.32-2.28 (m, 1H);  13C NMR δ 199.6, 149.5, 136.9, 133.9, 
133.7, 133.2, 130.8, 129.0, 128.4, 125.4, 46.0, 36.6, 27.0. 
5-(Nitrophenyl)pentan-2-one (32a).  The general procedure of Bull et al.17 was 
followed.  A 50-mL, round-bottomed flask, equipped with a magnetic stirrer and a reflux 
condenser was charged with acid 31a (0.14 g, 0.55 mmol) in DMF (10 mL).  Potassium 
carbonate (0.2 g) was added, and the reaction mixture stirred at 50 °C for 3 h.  After 
cooling to room temperature, H2SO4 (10 mL, 0.25 M ) was added and the mixture was 
extracted three times with ether (10 mL).  The ether extracts were washed with saturated 
aqueous NaCl, dried (MgSO4), filtered, and concentrated.  The residue was 
chromatographed using 10% ether in hexanes to afford 32a (0.10 g, 93%) as a light 
brown oil.  IR 1714, 1609, 1526, 1350, 745 cm-1; 1H NMR δ 7.89 (d, 1H, J = 8.2 Hz), 
7.53 (td, 1H, J = 7.4, 1.1 Hz), 7.38-7.32 (m, 2H), 2.87 (t, 2H, J = 7.9 Hz), 2.53 (t, 2H, J = 
7.1 Hz), 2.16 (s, 3H), 2.00-1.90 (m, 2H); 13C NMR δ 208.6, 149.7, 137.0, 133.3, 132.3, 
127.5, 125.0, 43.3, 32.3, 30.3, 24.9.  
4-(2-Nitrophenyl)-1-phenylbutan-1-one (32b).  The general procedure of Bull et al.17 
was followed.  A 250-mL, round-bottomed flask, equipped with a magnetic stirrer and a 
reflux condenser was charged with acid 31b (1.09 g, 3.47 mmol) in DMF (70 mL).  
Potassium carbonate (3.00 g) was added and the reaction mixture stirred at 50 °C for 3 h.  
After being allowed to cool, H2SO4 (20 mL, 0.25 M) was added and the mixture was 
extracted three times with ether (50 mL).  The ether extracts were washed with saturated  
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aqueous NaCl, dried (MgSO4), filtered, and concentrated.  The residue was 
chromatographed using 10% ether in hexanes to afford 32b (0.54 g, 54%) as a light 
brown residue, which crystallized on standing, mp 43-45 ºC.  IR 1686, 1598, 1524, 1346, 
741 cm-1; 1H NMR δ 8.12 (dd, 1H, J = 7.1, 1.6 Hz), 7.97-7.89 (m, 2H), 7.62-7.33 (m, 
6H), 3.08 (t, 2H, J = 7.1 Hz), 2.99 (t, 2H, J = 7.6 Hz), 2.18-2.08 (m, 2H); 13C NMR δ 
137.2, 134.1, 133.5, 133.4, 132.3, 130.6, 129.0, 128.9, 128.4, 127.5, 125.1, 38.3, 32.6, 
25.5.   
Representative Procedures for Reductive Cyclization: 2-Methyl-2,3,4,5-tetrahydro-
1H-benzo[b]azepine (8). 
Method A: A 100-mL, three-necked, round-bottomed flask, equipped with a magnetic 
stirrer, a septum, a hydrogen gas inlet and a ¼ argon-filled balloon as an outlet was 
charged with 32a (0.10 g, 0.48 mmol) in methanol (30 mL).  Palladium-on-carbon (5%, 
0.25 g) was added, and hydrogen gas from a balloon was introduced to the flask.  The 
reaction was stirred overnight under hydrogen. The crude reaction mixture was 
concentrated, diluted with ether (15 mL) and filtered through a pad of Celite 545® topped 
with a layer of MgSO4 to remove the catalyst.  The filtrate was concentrated and 
chromatographed using 5-10% ether in hexanes to give 8 (0.02 g, 29%) as light yellow 
crystals, mp 69-70 ºC.  IR 3326, 2921, 1432,761 cm-1; 1H NMR δ 7.09-7.01 (m, 2H), 
6.82 (t, 1H, J = 7.4 Hz), 6.73 (d, 1H,  J = 7.1 Hz), 3.38 (s, 1H), 2.94-2.65 (m, 2H), 1.94-
1.82 (m, 2H), 1.55-1.32 (m, 3H), 1.24 (d, 3H, J = 6.0 Hz); 13C NMR δ 130.9, 126.9, 
121.3, 120.2, 54.1, 39.7, 35.9, 26.6, 24.5. 
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Method B: A 100-mL, three-necked, round-bottomed flask equipped with a magnetic 
stirrer, a septum, and a ¼ argon-filled balloon as an outlet was charged with 32a (0.07 g, 
0.34 mmol) in methanol (30 mL).  Palladium-on-carbon (5%, 0.20 g) was added, and neat 
triethylsilane (1.5 mL, 1.09 g, 9.39 mmol) was added dropwise.  The reaction mixture 
was stirred overnight at room temperature.  The crude reaction mixture was concentrated, 
diluted with ether (10 mL) and filtered through a pd of Celite 545® topped with a layer 
of MgSO4 to remove the catalyst.  The filtrate was concentrated nd chromatographed to 
afford 8 (0.03 g, 59%). 
 2-Phenyl-2,3,4,5-tetrahydro-1H-benzo[b]azepine (12).  A 50-mL, three-necked, 
round-bottomed flask, equipped with a magnetic stirrer, a septum, a hydrogen gas inlet 
and a ¼ argon-filled balloon as an outlet was charged with 32b (0.30 g, 0.48 mmol) in 
methanol (50 mL).  Palladium-on-carbon (5%, 0.80 g) was added and hydrogen gas was 
bubbled through the mixture for hydrogenation.  The reaction was stirred overnight under 
hydrogen by means of hydrogen-filled balloon.  The crude reaction mixture was 
concentrated, diluted with ether (20 mL) and filtered through a pad of Celite 545® topped 
with a layer of MgSO4 to remove the catalyst.  The filtrate was concentrated and 
chromatographed using 5-10% ether in hexanes to give 12 (0.04 g, 17%) as a light brown 
oil.  IR 3377, 2928, 1721, 1619, 1496, 747 cm-1;  1H NMR δ 7.29-7.24 (m, 2H), 7.20-7.15 
(m, 3H), 7.04-7.99 (m, 2H), 6.74-6.63 (m, 2H), 3.54 (s, 1H), 2.65 (t, 2H, J = 7.1 Hz), 
2.49 (t, 2H, J = 7.4 Hz), 1.77-1.60 (m, 3H); 13C NMR δ 144.4, 142.9, 129.9, 128.8, 128.7, 




Method B: A 100-mL, three-necked, round-bottomed flask, equipped with a magnetic 
stirrer, a septum, and a ¼ argon-filled balloon as an outlet was charged with 32b (0.1 g, 
0.37 mmol) in methanol (30 mL).  Palladium-on-carbon (5%, 0.30 g) was added, and neat 
triethylsilane (3 mL, 2.18 g, 18.78 mmol) was added ropwise.  The reaction mixture was 
stirred overnight at room temperature.  The crude reaction mixture was concentrated, 
diluted with ether (10 mL) and filtered through a pd of Celite 545® topped with a layer 
of MgSO4 to remove the catalyst.  The filtrate was concentrated nd chromatographed to 
afford 12 (0.04 g, 48%). 
Methyl 2-(2-nitrophenyl)hex-5-enoate (34a).  A 100-mL, three-necked, round-
bottomed flask, equipped with a magnetic stirrer and  reflux condenser was charged with 
28 (0.2 g, 1.02 mmol) in DMF (15 mL).  Potassium carbonate (0.5 g, 3.6 mmol) and 18-
crown-6 (0.20 g) were added, and the reaction was stirred for 5 min.  To the resulting 
blue mixture were added KI (0.40 g) and a solution of 4-bromobutene (33a) (0.20 g, 1.48 
mmol) in 3 mL of DMF.  The reaction was stirred for2 days at room temperature.  Water 
(100 mL) was added, and the mixture was extracted three times with ether (20 mL).  The 
ether extracts were washed with water, saturated aqueous NaCl, dried (MgSO4), filtered, 
and concentrated.  The oily residue was chromatographed using 5-10% ether in hexanes 
to afford 34a (0.13 g, 50%) as a yellow oil.  IR 1738, 1531, 1353 cm-1; 1H NMR δ 7.86 
(dd, 1H, J = 8.2, 1.2 Hz), 7.62-7.53 (m, 2H), 7.43 (td, 1H, J = 8.5, 1.8 Hz), 5.81-5.70 (m, 
1H), 5.00 (dd, 2H, J = 10.8, 1.6 Hz), 4.20 (t, 1H, J = 7.5 Hz), 3.66 (s, 3H), 2.35-2.23 (m, 
1H), 2.11-1.91 (m, 3H); 13C NMR δ 173.4, 149.9, 146.2, 137.4, 133.4, 130.3, 128.5, 




Methyl 5-methyl-2-(2-nitrophenyl)hex-5-enoate (34b).  A 50-mL, three-necked, round-
bottomed flask, equipped with a magnetic stirrer and  reflux condenser was charged with 
28 (0.10 g, 0.51 mmol) in DMF (10 mL).  Potassium carbonate (0.25 g, 1.8 mmol) and 
18-crown-6 (0.20 g) were added, and the reaction was stirred for 5 min.  To the resulting 
blue mixture a solution of 4-iodo-2-methylbutene (33b) (0.10 g, 0.50 mmol) in DMF (3 
mL) was added.  The reaction was stirred for 2 days at room temperature.  Water (50 mL) 
was added and the mixture was ether extracted three times.  The ether extracts were 
washed with water, saturated aqueous NaCl, dried (MgSO4), filtered, and concentrated.  
The oily residue was chromatographed using 5-10% ether in hexanes to afford 34b (74 
mg, 55%) as a yellow oil.  IR 1736, 1528, 1353 cm-1; 1H NMR δ 7.88 (d, 1H, J = 8.2 Hz), 
7.65-7.56 (m, 2H), 7.45 (td, 1H, J = 8.7, 2.2 Hz), 4.75 (s, 1H), 4.66 (s, 1H), 4.20 (t, 1H, J 
= 7.1 Hz), 3.68 (s, 3H), 2.38-2.31 (m, 1H), 2.08-1.98 (m, 3H), 1.73 (s, 3H); 13C NMR δ 
173.4, 144.6, 133.8, 133.4, 130.3, 128.9, 128.5, 12.7, 111.3, 52.6, 45.9, 35.9, 31.1, 22.5.     
2-(2-Nitrophenyl)hex-5-enoic acid (35a).  A 250-mL, round-bottomed flask, equipped 
with a magnetic stirrer and a reflux condenser was charged with 34a (0.95 g, 3.81 mmol) 
in THF (50 mL), and alcoholic KOH (50 mL, 1 M) was added.  The mixture was stirred 
overnight at room temperature, and the reaction progress was monitored by TLC.  Water 
(50 mL) was added, and the mixture acidified with 1 M  HCl solution and extracted three 
times with CH2Cl2 (50 mL).  The organic extracts were washed with saturated aqueous 
NaCl, dried (MgSO4), filtered, and concentrated.  The oily residue was chromatographed 
using 20% ether in hexanes to afford 35a (0.86 g, 95%) as a yellow oil.  IR 3678-2651, 
1709, 1527, 1351 cm-1; 1H NMR δ 11.28 (br s, 1H), 7.92 (dd, 1H, J = 8.2, 1.6 Hz), 7.60 
(td, 1H, J = 7.1, 1.1 Hz), 7.52 (dd, 1H, J = 7.5, 1.1 Hz), 7.44 (td, 1H, J = 8.2, 1.1 Hz), 
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5.81-5.68 (ddt, 1H, J = 9.3, 6.6 Hz), 5.00 (2d, 2H, J = 15.9, 12.1 Hz), 4.22 (t, 1H, J = 7.1 
Hz), 2.35-2.24 (m, 1H), 2.10-1.19 (m, 3H); 13C NMR δ 179.2, 149.7, 137.2, 133.6, 133.1, 
130.7, 128.8, 125.3, 116.4, 64.1, 31.9, 31.7. 
5-Methyl-2-(2-nitrophenyl)hex-5-enoic acid (35b).  A 100-mL, round-bottomed flask, 
equipped with a magnetic stirrer and a reflux condenser was charged with 34b (0.20 g, 
0.75 mmol) in THF (15 mL), and alcoholic KOH (10 mL, 1 M) was added.  The mixture 
was stirred overnight at room temperature, and the reaction progress was monitored by 
TLC.  Water (20 mL) was added, and the mixture acidifie  with 1 M HCl solution and 
was extracted three times with CH2Cl2 (20 mL).  The organic extracts were washed with 
saturated aqueous NaCl, dried (MgSO4), filtered, and concentrated.  The oily residue was 
chromatographed using 20% ether in hexanes to afford 35b (0.16 mg, 83%) as a yellow 
oil.  IR 3075, 1709, 1572, 1350 cm-1; 1H NMR δ 10.62, (br s, 1H), 7.91 (dd, 1H, J = 8.2, 
1.1 Hz), 7.63-7.52 (td, 2H, J = 7.6, 1.1 Hz), 7.44 (td, 1H, J = 8.2, 1.6 Hz), 4.73 (s, 1H), 
4.63 (s, 1H), 4.19 (t, 1H, J = 7.1 Hz), 2.39-2.31 (m, 1H), 2.04-1.93 (m, 3H), 1.69 (s, 3H); 
13C NMR δ 179.2, 149.7, 144.4, 133.6, 133.2, 130.7, 128.8, 125.2, 111.6, 46.2, 25.8, 
30.5, 22.5.   
1-Nitro-2-(pent-4-en-1-yl)benzene (36a).  The general procedure of Bull et al.17 was 
followed.  A 250-mL, round-bottomed flask, equipped with a magnetic stirrer and a 
reflux condenser was charged with 35a (0.86 g, 3.65 mmol) in DMF (75 mL).  Potassium 
carbonate (2.2 g, 15.9 mmol) was added and the reaction stirred at 50 °C for 3 h.  After 
cooling to room temperature, H2SO4 (20 mL, 0.25 M) was added, and the mixture was 
extracted three times with ether (50 mL).  The ether extracts were washed with saturated  
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aqueous NaCl, dried (MgSO4), filtered, and concentrated.  The residue was 
chromatographed using 5-10% ether in hexanes to afford 36a (0.46 g, 65%).  IR 1641, 
1525, 1348 cm-1; 1H NMR δ 7.88 (dd, 1H, J = 9.3, 1.1 Hz), 7.51 (td, 1H, J = 8.7, 1.1 Hz), 
7.33 (td, 2H, J = 7.1, 1.6 Hz), 5.90-5.76 (m, 1H), 5.08-4.98 (dd, 2H, J = 15.3, 1.6 Hz), 
2.89 (t, 2H, J = 7.6 Hz), 2.13 (td, 2H, J = 7.1 Hz), 1.80-1.70 (m, 2H); 13C NMR δ 138.4, 
133.1, 132.3, 127.3, 125.0, 115.5, 33.9, 32.8, 30.2.       
1-(4-Methylpent-4-en-1-yl)-2-nitrobenzene (36b).  The general procedure of Bull et
al.17 was followed.  A 50-mL, round-bottomed flask, equipped with a magnetic stirrer 
and a reflux condenser was charged with 35b (0.10 g, 0.40 mmol) in DMF (10 mL).  
Potassium carbonate (0.20 g, 1.45 mmol) was added and the reaction stirred at 50 °C for 
3 h.  After being allowed to cool, H2SO4 (10 mL, 0.25 M) was added, and the mixture 
was extracted three times with ether (10 mL).  The ether extracts were washed with 
saturated aqueous NaCl, dried (MgSO4), filtered, and concentrated.  The residue was 
chromatographed using 5-10% ether in hexanes to afford 36b (0.08 g, 90%).  IR 1611, 
1522, 1347 cm-1; 1H NMR δ 7.94 (dd, 1H, J = 8.2, 1.1 Hz), 7.85 (dd, 1H, J = 7.7, 1.1 Hz),  
7.49 (td, 1H, J = 8.7, 1.1 Hz), 7.35-7.30 (m, 1H), 4.73 (s, 1H), 4.69 (s, 1H), 2.85 (t, 2H, J
= 7.7 Hz), 2.58 (s, 3H), 2.10 (t, 2H, J = 7.1 Hz), 1.83-1.72 (m, 2H); 13C NMR δ 145.4, 
137.7, 133.9, 133.4, 133.2, 133.1, 132.3, 127.2, 124.9, 110.8, 37.9, 32.9, 28.9, 22.6, 20.7. 
Ozonolysis-Wittig Sequence: (E)- and (Z)-Methyl 6-(2-nitrophenyl)hex-2-enoate 
(39).  The procedure of Bunce and co-workers14 was used.  A 250-mL, round-bottomed 
flask, was charged with 36a (1.3 g, 6.79 mmol) in MeOH (100 mL) and the solution was 
ozonized at -78 °C until TLC indicated complete consumption of starting material.   
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Excess ozone was purged with a stream of dry N2, and dimethyl sulfide (5.08 g, 6.00 mL, 
84.9 mmol) and p-TsOH (200 mg) were added.  The solution was gradually warmed to 
room temperature and stirred for 8 h.  The reaction was concentrated, diluted with ether, 
washed with saturated aqueous NaHCO3 and saturated aqueous NaCl and dried (MgSO4), 
filtered, and concentrated to afford aldehyde 37 (1.2 g, 92%) as a yellow oil.  The product 
was used for the next reaction step without further pu ification.  Into 50-mL, round-
bottomed flask, a solution of aldehyde 37 (0.1 g, 0.50 mmol) in benzene (10 mL) was 
added.  To the stirred solution was added methyl triphenylphosphoranylidene acetate (38) 
(0.40 g, 1.20 mmol) and the reaction was refluxed for 3 h.  After cooling to room 
temperature, the mixture was concentrated and chromatographed using 20% ether in 
hexanes to afford the two isomeric products (E)-39 isomer (98 mg, 83%) and (Z)-39 
isomer (2 mg, 2%), both as yellow oils.  E isomer: IR: 1723, 1657, 1526, 1348 cm-1; 1H 
NMR δ 7.90 (dd, 1H, J = 8.2, 1.1 Hz), 7.53 (td, 1H, J = 7.7, 1.1 Hz), 7.38-7.28 (m, 2H), 
7.03-6.93 (dt, 1H, J = 15.4, 7.1 Hz), 5.86 (dt, 1H, J = 17.0, 1.6 Hz), 3.73 (s, 3H), 2.90 (t, 
2H, J = 7.7 Hz), 2.34-2.26 (m, 2H), 1.88-1.78 (m, 2H); 13C NMR δ 167.3, 148.7, 137.0, 
133.3, 132.2, 127.6, 125.1, 121.9, 51.8, 32.8, 32.3, 29.3.  
Z isomer: 1H NMR δ 7.91 (dd, 1H, J = 8.2, 1.1 Hz), 7.52 (td, 1H, J = 7.7, 1.1 Hz), 7.36-
7.32 (m, 2H), 6.31-6.22 (dt, 1H, J = 11.5, 7.7 Hz), 5.82 (dt, 1H, J = 11.5 Hz), 3.71 (s, 
3H), 2.92 (t, 2H, J = 7.7 Hz), 2.80-2.73 (qd, 2H, J = 7.7, 1.6 Hz), 1.86-1.76 (m, 2 H); 13C 
NMR δ 166.7, 149.4, 137.0, 132.8, 132.0, 127.0, 124.7, 120.0, 51.0, 32.7, 29.8, 28.7.      
Methyl 2-(2,3,4,5-Tetrahydro-1H-benzo[b]azepin-2-yl)acetate (40).  The procedure of 
Bunce and coworkers15 was used.  Into a 100-mL, three-necked, round-bottomed flask, 
equipped with magnetic stirring, a reflux condenser and a nitrogen inlet were placed (E)  
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39 (71 mg, 0.27 mmol), acetic acid (10 mL) and iron powder (0.15 g, 2.67 mmol) (>100 
mesh).  The mixture was heated with stirring at 115ºC until thin layer chromatography 
indicated complete consumption of the starting materi l.  After being allowed to cool the 
crude reaction mixture filtered through Celite 545®.  Water was added, and the mixture 
was extracted three times with ether (10 mL).  The ether extracts were washed with 
saturated aqueous NaCl dried (MgSO4), filtered, and concentrated.  The crude material 
was chromatographed using 15% ether in hexanes to afford 40 (50 mg, 83%) as a yellow 
oil.  IR 3355, 1731 cm-1; 1H NMR δ 7.08-7.01 (m, 2H), 6.84 (td, 1H, J = 7.1, 1.1 Hz), 
6.75 (d, 1H, J = 7.7, 1.1 Hz), 4.23 (br s, 1H), 3.70 (s, 3H), 3.35-3.27 (m, 1H), 2.75 (m, 
2H), 2.56-2.47 (dd, 1H, J = 9.8, 6.0 Hz), 2.41 (dd, 1H, J = 15.9, 3.8 Hz), 1.91-1.74 (m, 
2H), 1.68-1.45 (m, 2H); 13C NMR δ 173.2, 148.0, 134.6, 130.7, 127.1, 121.8, 120.9, 54.3, 
52.1, 40.2, 37.8, 35.7, 25.3.       
(E)-Ethyl 3-methyl-6-(2-nitrophenyl)hex-2-enoate (42).  A 50-mL, three-necked, 
round-bottomed flask, equipped with a magnetic stirrer and a condenser was charged 
with ethyl dimethylphosphonoacetate (4) (0.10 g, 0.51 mmol) in dry THF (10 mL).  
Sodium hydride (0.03 g, 1.25 mmol) was added, while the solution was stirring under 
nitrogen at 0 ºC (ice bath).  The reaction mixture was stirred for 1.5 h.  Ketone 32a (0.10 
g, 0.48 mmol) was added, and the reaction mixture was allowed to warm to room 
temperature and was stirred overnight at room temperature.  The reaction mixture was 
quenched with saturated aqueous NaHCO3 and extracted three times with ethyl acetate 
(10 mL).  The organic phase was washed with saturated queous NaCl, dried (MgSO4), 
filtered, and concentrated to afford the E isomers of 42 (60 mg, 44%), which was used for 
next reaction step without further purification.  IR 1714, 1648, 1526, 1349 cm-1; 1H NMR 
52 
 
δ 7.89 (td, 2H, J = 7.7, 1.1 Hz), 7.56-7.49 (m, 2 H), 7.38-7.32 (m, 4H), 5.69 (s, 2H), 4.14 
(q, 4H, J = 7.1 Hz), 2.95-2.84 (td, 4H, J = 7.7 Hz), 2.75 (t, 2H, J = 7.7 Hz), 2.24 (t, 2H, J
= 7.7 Hz), 2.18 (s, 6H), 1.91-1.82 (m, 4H), 1.27 (t, 6H, J = 7.1 Hz); 13C NMR δ 167.0, 
166.7, 159.7, 159.2, 149.9, 137.6, 137.2, 133.3, 13.2, 132.2, 127.5, 127.3, 125.1, 125.0, 
117.1, 116.4, 59.9, 41.0, 33.5, 33.3, 32.9, 32.3, 29.3, 28.7, 25.3, 24.9, 19.0, 14.6.    
Ethyl 2-(2-methyl-2,3,4,5-tetrahydro-1H-benzo[b]azepin-2-yl)acetate (43).  The 
procedure of Bunce and coworkers20 was used.  Into a 100-mL, round-bottomed flask, 
equipped with magnetic stirring, a reflux condenser and a nitrogen inlet, was placed 42
(0.10 g, 0.36 mmol), acetic acid (25 mL) and of iron powder (0.20 g, 3.57 mmol) (>100 
mesh).  The mixture was heated with stirring at 115ºC until thin layer chromatography 
indicated complete consumption of the starting materi l.  After cooling to room 
temperature, the crude reaction mixture filtered through Celite 545®.  Water was added 
and the mixture was extracted three times with ether (10 mL).  The ether extracts were 
washed with saturated aqueous NaCl, dried (MgSO4), filtered, and concentrated.  The 
crude material was chromatographed using 10% ether in hexanes to afford 43 (30 mg, 
38%).  IR 3343, 1728, 1481 cm-1; 1H NMR δ 7.06-7.00 (m, 2H), 6.85 (td, 1H, J = 7.6, 1.1 
Hz), 6.76 (d, 1H, J = 7.6 Hz), 4.31 (s, 1H), 4.13 (q, 2H, J = 7.1 Hz), 2.76-2.71 (m, 3H), 
2.48 (d, 1H, J = 14.8 Hz), 2.26 (d, 1H, J = 14.8 Hz), 1.78-1.63 (m, 4H), 1.28-1.23 (t, 6H, 
J = 7.1 Hz); 13C NMR δ 172.4, 146.1, 134.8, 130.3, 127.0, 122.3, 121.9, 60.6, 54.5, 44.2, 
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SYNTHESIS OF NITROGEN HETEROAROTINOIDS  
FOR ANTICANCER ACTIVITY 
Introduction 
 Retinoids are a class of chemical compounds structurally related to vitamin A. 
Naturally occurring retinoids such as trans-retinoic acid (1), 9-cis-retinoic acid (2) and 
13-cis-retinoic acid (3) are depicted in Figure 3.1.  They have medicinal use due to their 
importance for regulation of cell proliferation and differentiation throughout the body.  
Studies have shown anticancer activity of natural and synthetic retinoids against skin, 
breast, lung, ovarian and uterine cancer.1  Some synthetic retinoids (Figure 3.2),1,2 such as 
arotinoid TTNPB (4), etretinate (5) and fenretinide (6),3 have shown potent anticancer 
activity.  The application of these retinoids, however, was limited due to their 


























 Retinoids exert their therapeutic activity by interaction with and activation of a 
specific group of nuclear receptors, termed retinoid receptors.1-3  The retinoid receptors 
are divided into two distinct types, namely the retinoic acid receptors (RARs) and the 
retinoid X receptors (RXRs).  For each type, three receptor subtypes, namely RARα, -β, 
and -γ and RXRα, -β, and -γ, have been identified for a total of six retinoid receptors.3 
These retinoid receptors belong to the hormone receptor superfamily, and, as a group, this 
family of proteins regulate the transcription of genes that control a variety of metabolic, 
developmental, and differentiation pathways.  Misregulation of any one of these 
pathways could enhance carcinogenesis.  Compounds, such as retinoids, may regulate 
these receptors and are, therefore, potentially chemopreventive agents.3,4  
  Other research suggested that retinoids inhibit cell growth by inhibition of 
ornithine decarboxylase (ODC) induction.  Ornithine d carboxylase is an essential 
enzyme for the biosynthesis of polyamines.  Polyamines, such as putrescine (7), 
spermidine (8) and spermine (9), comprise a family of aliphatic cations (Figure 3.3) that 
occur ubiquitously in nature.  They are necessary for cell proliferation, differentiation and 
transformation and are involved in DNA, RNA, and protein synthesis, as well as in 
stabilizing membrane and cytoskeletal structures. Polyamines accumulate in larger 





Figure 3.3.  Polyamine cations. 
  
  It has also been found that treating some human erythroleukemia (HEL) cells 
with trans-retinoic acid (t-RA) results in cell differentiation accompanied bya 9-fold 
increase in tissue transglutaminase (TGase) activity.7  Tissue transglutaminases are Ca2+ 
dependent enzymes which catalyze the crosslinking of pr teins between an α-amino 
group of a lysine residue and a γ-carboxamide group of a glutamine residue, creating a  
inter- or intramolecular bond that is highly resistant to proteolysis.  There is evidence to 
prove that TGase induction is mediated through a pathw y involving retinoic acid 
receptors (RAR).8 
 Heteroarotinoids are a new class of synthetic retinoids structurally resembling 
arotinoids in that at least one aryl moiety is present within the molecular structure.  They 
have been designed to mimic the anticancer activity of retinoids.  They have been called 
heteroarotinoids since they possess an aryl ring fused to saturated five- or six-membered 
ring containing a heteroatom as shown in Figure 3.4.9  Intensive studies on the 
modification of heteroarotinoid structures have been reported involving the insertion of  
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different linkers to connect the two aryl rings.  Structures with two-atom linker groups, 
such as an amide 13, an alkene 14, an ester 15 or an N-methoxyamide 16, have been 
synthesized.  Structures with three-atom linkers, such as propenone 17, propenol 18, R-
hydroxyamide 19 and 1,4-diketone 20 as a four-atom linker, have also been reported 
(Figure 3.5).  All of these heteroarotinoids have shown potent anticancer activity with 
low toxicity.3,7 
 





Figure 3.5.  Heteroarotinoids with three- and four-atom linkers. 
  
 The search for flexible heteroarotinoids which bind freely with the receptors is the 
primary objective to enhance the specificity and activity of the anticancer agent.  
Incorporation of a more flexible linker between thearyl moieties provides more degrees 
of freedom that allow for better accommodation of the molecule in the receptor site.  A 
number of urea and thiourea linkers between the aryl rings have been synthesized and 
have shown marked flexibility as a ligand and more H-bonding interaction with the 
amino acids at the receptor site (Figure 3.6).  These flexible heteroarotinoids have 
potential anticancer activity against kidney and multiple types of cancer cells.3,10,11  
Sorafenib (BAY-43-9006) (21) (Figure 3.7) is a compound that was approved by the 
FDA and was developed to improve its hydrophilic property without losing its biological 
activity.  It has been shown to have potent anticancer activity against kidney cancer.  The 
enhanced hydrophilicity increases the drug concentration in the blood or plasma and 
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consequently, delivers a higher concentration to the tumor cells.11  Heteroarotinoids 22-
25 are structural analogs to the anticancer agent sorafenib (21).  Molecular modeling 
studies have shown that sorafenib (21) and heteroarotinoid 25 have the same binding sites 
on the receptor, where, both the urea groups in Sorafenib and the thiourea group in 25 
formed H-bonds with Glu501 and Asp594 as shown in Figure 3.7.  Thus, it is predictable 
that 25 would inhibit B-Raf.11a  B-Raf is a protein made by a human gene called BRAF. 
B-Raf regulates signal transduction serine/threonin-specific protien kinase that essential 
for cell growth and differentiation.  Active B-Raf mutants cause human cancer by 
accelerating cell growth.11b   
 
 





Figure 3.7.  Sorafenib (21) and 25 docked into the binding sites of B-Raf. 
 
 Structure activity relationship studies based on the model unit 10 suggests that 
alteration of the heteroatom, ring size and terminal side chain (Z group) may change the 
efficacy and specificity toward the retinoid receptor.  In general, insertion of a 
heteroatom in the five- or six-membered ring of thearotinoid backbone reduced the 
toxicity 1000-fold compared to trans-retinoic acid and arotinoids.12,13  Heteroarotinoids 
with six-membered rings exhibited greater specificity for RARβ, while other derivatives 
had specificity to other receptors.12,13   
 Compound 25 exhibited more potency than the clinical agent 4-
hydroxyphenylretin amide (4-HPR) against ovarian cacer.3  Chemoprevention activity 
by 4-HPR is thought to induce apoptosis through a retinoic acid receptor at low 
concentration.3b,3c  This high activity caused by the thiourea or urea group may be due to  
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the natural flexibility of the three-atom linker, which might allow a good fit into the 
RARs and therefore enhance the activity.  Moreover, a thiourea or urea function provides 
two -NH- groups capable of hydrogen bonding with the receptor, thus possibly improving 
the RAR selectivity.3  
 As a part of ongoing work on this project, we sought to insert a nitrogen atom in 
place of sulfur or oxygen in the arotinoid ring system.  Based on the results of related 
heteroarotinoids, these new derivatives have great potential as agents with high 
anticancer activity and low toxicity.  In comparison, the nitrogen atom is smaller than 
oxygen and sulfur.  Moreover, the nitrogen atom has a greater ability to hydrogen bond, 
which could allow new derivatives to easily fit in and bind to the receptor site.  
Furthermore, to overcome the solubility problem with heteroarotinoids containing sulfur 
and oxygen and increase the hydrophilicity, these new heteroarotinoids are able to form 
quaternary ammonium salts. This would provide greater solubility and could enhance the 
in vivo activity by increasing the blood concentration of the drug for distribution to the 
target tissue.    
Results and Discussion  
Synthesis of the Amine 
 The synthesis of selected target compounds began with the allylation of the LDA 
generated anion of ethyl isobutyrate (26) with methylallyl iodide (27) in THF to afford 
ester 28 in a yield of 59%.  Ester 28 was converted to acid 29 (96%) by basic hydrolysis 
using aqueous NaOH.  Finally, amine 31 was prepared by the reaction of acid 29 with 
diphenylphosphonic azide (30) in the presence of Et3N with benzene as solvent (Figure 
3.8).14  The conversion of a carboxylic acid to an amine using diphenylphosphonic azide 
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(30) and base involves a Curtius rearrangement15 as shown in Figure 3.8.  This reaction 
usually gives high yields of product, but with the volatile aliphatic amine 31, the yield 
was 72%. 
 
Figure 3.8.  Synthesis of amine 31. 
 
Mechanism of the Curtius Rearrangement 
  
 The first step of the Curtius rearrangement is the formation of an acyl azide (or 
acyl nitrene) 32 by displacement of azide form 30 by acid 29 (carboxylate) in the 
presence of Et3N and addition of azide to the resulting acyl phosphate as shown in Figure 
3.9.  This acyl nitrene is highly reactive and electrophilic.  Thermal decomposition of 
acyl nitrene 32 leads to migration of the alkyl substituent from carbon to the electron 
deficient nitrogen atom to give isocyanate 33 with release of nitrogen gas.  The 
isocyanate 33 was isolated and subjected to acidic hydrolysis with a mixture of 15% HCl 
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and acetic acid (1:1) to form the carbamic acid 34, which spontaneously decarboxylated.  
The free base amine 31 was released by basification of the solution containing the amine 































































Synthesis of the Heteroarotinoids 
 
 Amine 31 was spectroscopically pure and, due to its volatility, was used directly 
for the next reaction step.14  Nucleophilic aromatic substitution of 31 with 36 afforded the 
secondary amine 37 in 45% yield,16 which was converted to tertiary amine 38 (99%) by 
methylation with MeI using NaH in DMF as solvent.17  Compound 39 was obtained in 
95% yield by reduction of the nitro compound 38 with iron powder in the presence of 
NH4Cl in aqueous ethanol as solvent.
18  Protection of the amino group of 39 by 
acetylation with acetyl chloride in the presence of pyridine produced the acetamide 
derivative 40 in 97% yield.  Friedel-Crafts cyclization of 40 using AlCl3 in CH2Cl2 
formed the fused-ring compound 41 (53%).19  Deprotection of 41 was accomplished by 
acidic hydrolysis under reflux using 70% (v/v) H2SO4, followed by basification with 30% 
NaOH to produce diamine 42 in 92% yield.  The target heteroarotinoids 43 and 44 were 
obtained in 90% and 82% yields, respectively, by reaction of the isothiocyanate 
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 This project provides a new synthetic route for the synthesis of heteroarotinoids 
containing a saturated nitrogen heterocycle as a part of the core ring structure.  The key 
step of the synthetic scheme is the formation of the new amine derivative 31. All 
intermediates are stable structures formed in reasonably good yields.  Deprotection of the 
amino group of compound 41 with 70% v/v H2SO4 prove the stability of the 
heteroarotinoid ring even under strongly acidic conditions.  The target heteroarotinoids 
43 and 44 were obtained as crystalline solids. These new heteroarotinoids will be 














 All solvents were distilled prior to use. Other reag nts were used as received from 
various vendors.  All reactions were run under dry nitrogen in oven-dried glassware.  
Reactions were monitored by TLC on hard layer silica gel GF plates (Analtech No. 
21521) using UV detection.  Preparative separations were performed using one of the 
following methods: (1) PTLC on 20-cm x 20-cm silica gel GF plates (Analtech No. 
02015) or (2) flash column chromatography on silica gel (Davison®, grade 62, 60-200 
mesh) containing UV-active phosphor (Sorbent Technologies No. UV-05).  In each case, 
band elution was monitored using a hand-held UV-lamp.  IR spectra were run as thin 
films on NaCl disks.  1H-NMR and 13C-NMR spectra were measured in CDCl3 at 300 
MHz and 75 MHz, respectively, and were referenced to in ernal (CH3)4Si;  coupling 
constants (J) are in Hz. 
Ethyl 2,2,4-Trimethyl-4-pentenoate (28).  The method of Walborsky et al.14 was 
followed.  A 500-mL, three-necked, round-bottomed flask, equipped with a magnetic 
stirrer, a septum, a condenser and a nitrogen inlet, was charged with diisopropylamine 
(15.9 g, 22 mL, 157 mmol) in 200 mL of freshly distilled THF.  The flask was cooled to  
-70 °C (dry ice/acetone), and n-butyllithium (2.5 M, 63 mL, 157.5 mmol) was added to 
the solution.  After 5 min, ethyl isobutyrate (26, 14 g, 120.5 mmol) was added dropwise.  
Stirring was continued for 1 h at -70 °C.  A solution of 3-iodo-2-methylpropene (27, 22 g, 
120.5 mmol) was added dropwise, and the reaction was stirred overnight with warming to 
ambient temperature.  The reaction mixture was poured into a mixture of ice and 1 M 
HCl, and the product was extracted with ether (3 × 100 mL).  The combined ether    
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extracts were washed with saturated aqueous NaCl, dried (MgSO4), filtered, and 
concentrated.  Vacuum distillation afforded 28 (12.8 g, 64%) as colorless liquid, bp 50 ºC 
(1.8 mm).  IR: 3078, 1729, 1645, 895 cm-1; 1H-NMR: δ 4.79 (s, 1H), 4.65 (s, 1H), 4.08 
(q, 2H, J = 7.1 Hz), 2.31 (s, 2H), 1.66 (s, 3H), 1.25 (t, 3H, J = 7.1 Hz), 1.17 (s, 6H); 13C-
NMR:  δ 177.7, 142.3, 113.9, 60.1, 48.2, 41.7, 25.4, 23.3, 13.9.  
2,2,4-Trimethyl-4-pentenoic acid (29).  A 500-mL, round-bottomed flask, equipped 
with a magnetic stirrer and a reflux condenser, wascharged with compound 28 (11.2 g, 
66.6 mmol) in 25 mL of MeOH.  An aqueous solution of NaOH (20%, 30 mL) was added 
to the solution, and the reaction mixture was refluxed overnight at 60-70 °C.  After being 
allowed to cool to room temperature, 50 mL of water was added, and the mixture was 
acidified with 1 M HCl.  The product was extracted with ether (3 × 100 mL), and the 
combined ether extracts were washed with saturated queous NaCl, dried (MgSO4), 
filtered, and concentrated.  Vacuum distillation afforded acid 29 (9.04 g, 96%) as a 
colorless liquid, bp 83 °C (1.8 mm).  IR: 3077, 1703, 1644, 895 cm-1; 1H-NMR: δ 11.15 
(s, 1H), 4.82 (s, 1H), 4.70 (s, 1H), 2.34 (s, 2H), 1.71 (s, 3H), 1.21 (s, 6H); 13C-NMR: δ 
185.3, 142.6, 114.8, 48.5, 42.3, 25.7, 23.9.  
2,4-Dimethyl-4-penten-2-amine (31).  A 250-mL, three-necked, round-bottomed flask, 
equipped with a magnetic stirrer, a septum, a reflux condenser and a nitrogen inlet, was 
charged with compound 29 (2.2 g, 15.6 mmol) and TEA (2.9 g, 4 mL, 28.6 mmol) in 25 
mL of dry benzene.  The flask was cooled to 0 ºC (ice bath), and diphenylphosphonic 
azide (30, 6.3 g, 23.2 mmol) was added dropwise with stirring.  The reaction mixture was 
stirred at 0 °C for 1 h, and then at room temperature for 1 h and finally at reflux for 3 h 
(evolution of nitrogen).  The solution was cooled, ther (250 mL) was added and the 
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organic layer was washed three times with water.  The organic layer was dried (Na2SO4), 
filtered, and concentrated.  To the concentrated residu  was added a mixture of 15% HCl 
(10 mL) and AcOH (10 mL), and the reaction was stirred overnight at room temperature.  
Water was added, and the aqueous layer was washed with ether (3 × 50 mL).  The 
aqueous layer was cooled (ice bath) and basified by ropwise addition of 10% NaOH 
solution, and the product was extracted with ether (3 × 50 mL).  The combined ether 
extracts were washed with water, and saturated aqueous NaCl, and then dried over KOH.  
The solvent was evaporated to give 31 (1.2 g, 72%) as a light yellow liquid, which was 
used for the next step without purification.  IR: 3355, 2967, 1639, 891 cm-1; 1H-NMR: δ 
4.91 (s, 1H), 4.72 (s, 1H), 2.10 (s, 2H), 1.82 (s, 3H), 1.13 (s, 6H); 13C-NMR: δ 143.4, 
114.8, 52.8, 46.5, 31.3, 25.5. 
N-(2,4-Dimethyl-4-penten-2-yl)-4-nitroaniline (37).  A 250-mL, pressure vessel 
(ChemGlass, CG-1880-R-03), equipped with a magnetic stirrer, was charged with the 
amine 31 (2.2 g, 19.7 mmol) and 1-fluoro-4-nitrobenzene 36 (2.5 g, 17.7 mmol) in 15 mL 
of DMSO.  The vessel was sealed under nitrogen and heated at 80 °C for 48 h.  After 
cooling to room temperature, water was added, and the product was extracted with ether 
(3 × 75 mL).  The ether extract was washed with water nd saturated aqueous NaCl, then 
dried (Na2SO4), filtered,  and concentrated to give a yellow oil, which was 
chromatographed using 5-15% ether in hexane to afford 37 (1.8 g, 45%) as a yellow oil.  
IR: 3379, 1599, 1531, 1368, 834 cm-1;  1H-NMR: δ 8.05 (d, 2H, J = 9.3 Hz), 6.61 (d, 2H, 
J = 9.3 Hz), 4.94 (s, 1H), 4.72 (s, 1H), 4.63 (br s, 1H), 2.46 (s, 2H), 1.76 (s, 3H), 1.44 (s, 
6H);  13C-NMR:  δ 152.7, 142.2, 126.6, 116.3, 113.3, 54.3, 48.4, 28.8, 24.9.  
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 N-(2,4-Dimethyl-4-penten-2-yl)-N-methyl-4-nitroaniline (38).  A 50-mL, round-
bottomed flask, equipped with a magnetic stirrer, a reflux condenser and drying tube, was 
charged with compound 37 (70 mg, 0.3 mmol) in 5 mL of DMF.  Sodium hydride (50 
mg, 2 mmol) was added, and the mixture was stirred for 5 min, and then methyl iodide 
(3.0 g, 0.6 mmol) was added dropwise.  Stirring was continued overnight at room 
temperature.  Aqueous NH4Cl (10%, 5 mL) was added, and the product was extracted 
with ether (3 × 10 mL).  The ether extracts were washed with water and saturated 
aqueous NaCl, dried (MgSO4), filtered, and concentrated to give a yellow oil,which was 
chromatographed using 10-20% ether in hexane to afford 38 (70 mg, 99%) as a yellow 
oil.  IR: 1591, 1502, 1307, 837 cm-1; 1H-NMR: δ 8.06 (d, 2H, J = 9.3 Hz), 6.95 (d, 2H, J 
= 9.3 Hz), 4.91 (s, 1H), 4.75 (s, 1H), 3.02 (s, 3H), 2.47 (s, 2H), 1.72 (s, 3H), 1.41 (s, 6H);  
13C-NMR: δ 156.6, 142.7, 124.8, 119.7, 115.5, 59.6, 47.2, 37.5, 28.6, 24.6.  
N1-(2,4-Dimethyl-4-penten-2-yl)-N1-methyl-1,4-benzenediamine (39).  The basic 
procedure of Zhao et al.18 was followed.  A 250-mL, round-bottomed flask, equipped 
with a magnetic stirrer, and a reflux condenser, was charged with compound 38 (2.0 g, 
8.1 mmol), iron powder (3.0 g, 53.7 mmol, >100 mesh) and NH4Cl (1.0 g, 18.6 mmol) in 
100 mL of EtOH:H2O (3.6:1).  The reaction mixture was heated to 85 °C under N2 for 2 
h.  The reaction mixture was filtered through Celite 545®, treated with saturated aqueous 
NaHCO3 (100 mL), and extracted with ethyl acetate (3 × 100mL).  The organic layer was 
washed with saturated aqueous NaCl, dried (Na2SO4), filtered, and concentrated to afford 
a brown residue (1.67 g, 95%), which was spectroscopically pure and was used directly 
for the next reaction step.  IR: 3348, 1551 cm-1; 1H-NMR: δ  6.97 (d, 2H, J = 7.8 Hz), 
6.58 (d, 2H, J = 8.7 Hz), 4.84 (s, 1H), 4.71 (s, 1H), 3.81 (s, 2H), 2.72 (s, 3H), 2.22 (s, 
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2H), 1.81 (s, 3H), 1.06 (s, 6H);  13C-NMR: δ 144.1, 143.5, 129.5, 115, 114.6, 113.5, 58.2, 
46.5, 37.3, 25.7, 25.3.       
N-[4-(2,4-Dimethyl-4-penten-2-yl)methylamino)phenyl]acetamide (40).  A 250-mL, 
two-necked, round-bottomed flask, equipped with a mgnetic stirrer, a condenser and 
addition funnel was charged with compound 39 (1.0 g, 4.7 mmol) in 50 mL of pyridine.  
Acetyl chloride (3 mL) was added dropwise, and the mixture was stirred at room 
temperature for 2-3 h.  Water (100 mL) was added, an  the product was extracted with 
ether (3 × 50 mL).  The ether extracts were washed with saturated aqueous NaCl, dried 
(MgSO4), filtered, and concentrated, to give a brown residue, which was purified by 
chromatography using 30% ether in hexane to afford 40 (1.2 g, 97%) as a light yellow 
solid, mp 74-75 ºC.  IR: 3297, 1663, 887 cm-1; 1H-NMR: δ 7.45 (s, 1H), 7.37 (d, 2H, J = 
7.1 Hz), 7.09 (d, 2H, J = 7.1 Hz), 4.86 (s, 1H), 4.73 (s, 1H), 2.75 (s, 3H), 2.23 (s, 2H), 
2.15 (s, 3H), 1.82 (s, 3H), 1.08 (s, 6H); 13C-NMR: δ 168.7, 147.6, 143.9, 134.3, 128.8, 
120.0, 114.7, 58.1, 46.6, 37.1, 26.0, 25.2, 24.8.  
N-(1,2,2,4,4-Pentamethyl-1,2,3,4-tetrahydroquinolin-6-yl)acetamide (41).  The basic 
procedure of Faure t al.19 was followed.  A 250-mL, three-necked, round-bottomed 
flask, equipped with a magnetic stirrer, a septum, a reflux condenser and a nitrogen inlet, 
was charged with AlCl3 (5.0 g, 37.4 mmol) in 75 mL of CH2Cl2.  The flask was cooled at 
-70 °C (dry ice/acetone), and amide 40 (0.9 g, 3.4 mmol) in 15 mL CH2Cl2 was added 
dropwise.  Stirring was continued overnight with a gr dual warming to room temperature.  
The reaction was monitored by TLC.  The reaction mixture was poured into crushed ice, 
and the aqueous phase was extracted with CH2Cl2 (3 × 50 mL).  The combined organic  
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extracts were washed with saturated NaHCO3, water, and saturated aqueous NaCl, then 
dried (MgSO4), filtered, and concentrated to give a brown residue, which was 
chromatographed using 5-20% ethyl acetate in hexane to afford semisolid 41 (0.45 g, 
53%).  IR: 3289, 1655, 1610, 806 cm-1; 1H-NMR: δ 8.08 (s, 1H), 7.28-7.22 (m, 2H), 6.52 
(d, 1H, J = 8.2 Hz), 2.72 (s, 3H), 2.08 (s, 3H), 1.74 (s, 2H), 1.26 (s, 3H), 1.19 (s, 3H);  
13C-NMR: δ 169.0, 142.9, 134.4, 128.3, 125.4, 123.8, 120.1, 118.6, 112.6, 54.5, 53.2, 
52.7, 32.8, 31.7, 31.5, 28.1, 27.8, 24.5.  
1,2,2,4,4-Pentamethyl-1,2,3,4-tetrahydroquinolin-6-amine (42).  A 50-mL, round-
bottomed flask, equipped with a magnetic stirrer, and  reflux condenser, was charged 
with the amide 41 (0.15 g, 0.6 mmol) in 10 mL of 70% (v/v) of H2SO4.  The reaction 
mixture was refluxed overnight.  After being allowed to cool to room temperature, 10 mL 
of water was added and the mixture was basified with 30% NaOH.  The amine was 
extracted with ethyl acetate (3 × 15 mL).  The organic extracts were dried (Na2SO4), 
filtered and concentrated to give 42 (0.15 g, 92%) as a brown residue.  This compound 
was used without further purification.  IR: 3336, 1623 cm-1; 1H-NMR: δ 6.64 (s, 1H), 
6.50 (s, 2H), 3.64 (s, 2H), 2.69 (s, 3H), 1.74 (s, 2H), 1.28 (s, 6H), 1.17 (s, 6H); 13C-NMR: 
δ 139.3, 137.2, 135.8, 114.7, 114.2, 114.0, 53.4, 32.1, 31.7, 27.4.  
3-(1,2,2,4,4-Pentamethyl-1,2,3,4-tetrahydroquinolin-6-yl)-1-(4-nitrophenyl)thiourea 
(43).  A 50-mL, round-bottomed flask equipped with a magnetic stirrer, reflux condenser 
and nitrogen inlet was charged with the amine 42 (0.1 g, 0.5 mmol) in 5 mL of dry THF. 
To the stirred solution was added 4-nitrophenyl isothiocyanate (0.1 g, 0.5 mmol), and 
stirring was continued under nitrogen overnight at room temperature.  The solvent was  
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removed, and the mixture was subjected to chromatogr phy using 20-30% ether in 
hexane to afford 43 (0.18 g, 90%) as orange crystals, mp 151-153 ºC.  IR: 3335, 1596, 
1500, 1332, 1263, 851 cm-1; 1H-NMR: δ 8.17 (d, 2H, J = 9.3 Hz), 7.86 (br s, 2H), 7.78 (d, 
2H, J = 8.8 Hz), 7.08 (d, 1H, J = 2.2 Hz), 7.02 (dd, 1H, J = 8.8, 2.2 Hz), 6.63 (d, 1H, J = 
8.8 Hz), 2.82 (s, 3H), 1.81 (s, 2H), 1.31 (s, 6H), 1.28 (s, 6H); 13C-NMR: δ 179.6, 144.7, 
125.2, 124.7, 123.4, 123.1, 113.1, 54.9, 52.3, 32.9, 31.8, 31.4, 28.4.  Anal. Calcd. For 
C21H26N4O2S: C, 63.28; H, 6.57; N, 14.06.  Found: C, 63.06; H, 6.58; N, 13.92. 
1-(4-Ethoxycarbonylphenyl)-3-(1,2,2,4,4-pentamethyl-1,2,3,4-tetrahydroquinolin-6-
yl)thiourea (44).  A 100-mL, round-bottomed flask, equipped with a magnetic stirrer, 
reflux condenser and nitrogen inlet, was charged with the amine 42 (0.77 g, 3.76 mmol) 
in 100 mL of dry THF.  To the stirred solution was dded 4-ethoxycarbonylphenyl 
isothiocyanate (0.9 g, 4.34 mmol), and stirring was continued under nitrogen overnight at 
room temperature.  The solvent was removed, and the mixture was subjected to column 
chromatography using 20-40% ether in hexane to afford 44 (1.32 g, 82%) as a yellow 
solid, mp 154-155 ºC.  IR: 3287, 1712, 1500, 1274 cm-1; 1H-NMR: δ 8.18 (d, 2H, J = 8.8 
Hz), 7.88 (s, 1H), 7.84 (s, 1H), 7.78 (d, 2H, J = 8.8 Hz), 7.26 (ds, 1H, J = 2.2 Hz), 7.20 
(dd, 1H, J = 2.2, 8.8 Hz), 6.80 (d, 1H, J = 8.8 Hz), 4.52 (q, 2H, J = 7.1 Hz), 2.99 (s, 3H), 
1.98 (s, 2H), 1.54 (t, 3H, J = 7.1 Hz), 1.48 (s, 6H), 1.45 (s, 6H); 13C-NMR: δ 180.1, 
166.4, 130.7, 125.3, 123.5, 123.3, 113.0, 61.3, 54.9, 52.4, 32.9, 31.8, 31.4, 28.4, 14.7.  
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 Supramolecular chemistry has experienced rapid development within the last two 
decades.  It is defined as chemistry beyond the molecule, bearing on the organized 
entities of higher complexity that result from the association of two or more chemical 
species held together by intermolecular forces.1  The synthesis of well-defined molecular 
architectures will play a very crucial role because th  incorporation of spatially-defined 
and orientationally-controlled steric and/or electronic features into molecules is essential 
for dictating non-covalent interactions.  The forces responsible for the spatial 
organization between molecules include hydrogen bonding, metal coordination, 
hydrophobic interaction, van der Waals forces, π-π interaction, and electrostatic forces.1  
Studying the photophysical and electrochemical prope ties of these compounds is of great 
interest involving a variety of biomimetic, molecular self-assembly, host-guest chemistry, 
metal complexation, molecular machinery, and molecular imprinting… etc.  The 
porphyrins represent ideal building blocks for the formation of supramolecular materials.2  
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 Porphyrin is an aromatic system consisting of four pyrrole rings joined by four 
methine carbons (Figure 4.1).  The electronic system of the porphyrin ring has a total of 
22π electrons, only 18 of them participate in the aromatic stabilization.  Due to the 
anisotropic effect from the porphyrin ring current, the shielded N-H protons appear at 
very high field (-2 to -4 ppm) in the 1H-NMR spectrum, while the peripheral protons are 
deshielded and appear at 8-10 ppm.3  These protons have topological diversity, minimal 
conformational flexibility, and can be readily functionalized at several different sites, and 
thus fine-tuned to self-assemble and self-organize i  predefined architectures.4  
 
                     meso-substituted porphyrins                 β-substituted porphyrins 
Figure 4.1.  Basic structures of meso-substituted and β-substituted porphyrins. 
 Porphyrins have strong absorption bands in the visible light region,5 and their 
remarkable photoelectronic properties make them useful in various molecular devices. 
Zinc and magnesium porphyrins are coordinated by nitrogen ligands, and the 
coordination bond can exchange rapidly.  This feature has been applied to the formation 
of dynamic supramolecular porphyrin complexes.  Other stable metal porphyrins, such as 
Fe(III), Co(III), and Ru(II)CO porphyrins, also bind nitrogen ligands strongly.  They are 
not, however, suitable for dynamic systems because their exchange rates are too slow.5  
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Aromatic stacking between porphyrins is a frequently encountered motif arising from π-
stacking and/or crystal packing forces.  Cofacially stacked dimetalloporphyrins have the 
ability to facilitate catalytic proton coupled electron transfer (PCET) for the reduction of 
small molecules in the binding pocket.6  Moreover, columnar assemblies of aromatic 
building blocks may also be induced through interactions of peripheral substituents.7  A 
number of reports showed the formation of co-facial porphyrins which were joined by 
different linkers (Figure. 4.2) such as an amide and ether.8,9   
 
Figure 4.2.  Face to face porphyrins with amide and ether linkages. 
Synthesis of Porphyrins  
Rothemund method 
 The chemistry of meso-substituted porphyrins had its genesis with the work of 
Rothemund in 1935.10  He first investigated the synthesis of meso-tetramethylporphyrin 
by reaction of acetaldehyde and pyrrole (6) in methanol at various temperatures (Figure 
4.3).  This method has little application because of the low yield and the production of 
chlorin (dihydroporphyrin) 9 as a byproduct (Figure 4.4).  This method does not have any 




Figure 4.3.  Rothemund method for the synthesis of meso-tetramethylporphyrin. 
 
 
Figure 4.4.  Formation of cholrin as a byproduct along with porphyrin. 
Adler method 
 In the mid-1960s, Adler, Longo and coworkers reexamined the synthesis of meso-
substituted porphyrins.3,11,12  They performed a condensation of benzaldehyde (5) and 
pyrrole (6) (0.002 M) in a variety of acidic solvents at reflux in glassware open to the 
atmosphere (Figure 4.5).  The main solvents employed w re acetic acid and propionic 
acid, and the reaction was performed at high temperature.  A number of aryl-substituted 
porphyrins were prepared in higher yields than the Rothemund method.  This method can 
be used for the synthesis of porphyrins on a preparative scale from aldehydes that are  
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relatively stable.  The major limitations of the Adler method occur with aldehydes 
bearing substituents that do not survive refluxing with propionic acid, aryl aldehydes, 
(2,6-disubstitution) and aliphatic aldehydes.3  
 
Figure 4.5.  Adler method for porphyrin synthesis. 
Lindsey method 
 The Lindsey method was performed in two steps in one flask under mild 
conditions.3,13-15  In the first step, a solution of pyrrole and benzaldehyde (10 mM each) 
in CH2Cl2 at room temperature was treated with trifluoroacetic acid or BF3-etherate 
(Figure 4.6).  The ensuing condensation was found to plateau after 30-60 min.  In the 
second step, a stoichiometeric quantity of DDQ or p-chloranil was added, causing room 
temperature conversion of the porphyrinogen to the porphyrin (Figure 4.6).  This method 
has a broad scope because it provides higher yields than the previous methods.  It can be 
used for aldehydes which are unstable under Adler conditions and with fewer by-products 
being generated.  Lindsey’s method is preferable for the preparation of porphyrins from 
mixed aldehydes that are hard to purify using the Adler method.  The best application of 




Figure 4.6.  Two-step porphyrin synthesis (Lindsey method). 
  
 Besides the previous methods where pyrrole-aldehyds are the only reactants for 
porphyrin synthesis, porphyrins can also be synthesized via condensations of a 
dipyrromethane and an aldehyde (Figure 4.7).  Certain tr ns-A2B2-porphyrins can be 
obtained by condensations of a dipyrromethane and an aldehyde.  This condensation 
usually yields not only the desired trans-A2B2-porphyrin, but also other porphyrins such 
as cis-A2B2-isomers and A3B porphyrins.  This major limitation is due to acid- atalyzed 









 Our aim was to synthesize trans-A2B2 porphyrins substituted with polar 
functional groups, such as OH, NH2, COOH and a pyridine ring and to examine their 
NMR, IR, UV-VIS spectroscopic and fluorescence properties.  The polar functional 
groups have the ability to H-bond with other molecus to form a central cavity between 
themselves or to form flexible non-slipped, co-facially stacked porphyrins with different 
covalent and hydrogen bonding linkers.  These structu es were predicted to provide 
unique geometric systems that would be capable of binding small molecules in an interior 
pocket.  
 Dipyrromethanes were synthesized by heating freshly distilled pyrrole with an 
appropriate aldehyde with or without an acid catalyst (Figure 4.8).15   All porphyrins in 
this work were prepared by a condensation of dipyrromethane derivatives with an 
aldehyde in acetic acid in a system open to air for oxidation.  Dipyrromethanes and 
porphyrins were purified by column chromatography.  Certain Zn(II) complexes were 
synthesized by reaction of Zn(II) acetate with a porphyrin in a proper solvent as shown in 
Figures 4.9, 4.10 and 4.11.  
 























































































































Figure 4.11.  Synthesis of porphyrins 27 and 28 and the Zn(II) complex 29. 
 
Results and Discussion 
 In this project a number of trans-A2B2-prophyrins containing pyridine moieties 
and phenyl groups substituted with polar functional groups, such as OH, NH2 and CO2H, 
were synthesized and characterized by NMR, IR and UV-VIS spectroscopy.  The Zn(II) 
complexes of these polar porphyrins were solids and had limited solubility in common 
solvents, such as CHCl3, CH3CO2C2H5, MeOH, CH3CN, and DMSO, which made it 
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difficult to study the H-bonding interactions between porphyrin systems.  This impaired 
solubility is believed to be due to the presence of OH, NH2, CO2H groups and the 
pyridine ring in the porphyrin structure which coordinates with the Zn(II) metal of other 
molecules (Figure 4.12).  Thus, the usual solvents sited above are, unfortunately, not 






























 Chemicals were purchased from commercial sources and, unless specified, were 
used without further purification.  Dipyrromethane derivatives were prepared from 
freshly distilled pyrrole.  Reactions were monitored by TLC on hard layer silica gel GF 
plates (Analtech No. 21521) using UV detection.  Column chromatography was 
performed on silica gel (Davisil®, grade 62, 60-200 mesh).  Both 1H-NMR and 13C-NMR 
spectra were acquired in CDCl3 or DMSO-d6 using a Varian Inova 300 MHz or 400 MHz 
NMR spectrometer.  Chemical shifts (δ) are expressed in ppm relative to residual 
chloroform (1H: 7.26 ppm, 13C:77.16 ppm) or to TMS (0.00 ppm).  Fourier Transform 
Infrared (FT-IR) measurements were performed on a Varian 800 FT-IR spectrometer, and 
UV-VIS spectra were recorded on a Cary 5000 UV-VIS-NIR spectrophotometer.    
3-Pyridyldipyrromethane (15).  The procedure of Lindsey15 was followed.  A 500-mL, 
round-bottomed flask, equipped with a magnetic stirrer and a reflux condenser was 
charged with nicotinaldehyde (13) (10.17 g, 94.95 mmol) in freshly distilled pyrrole (6) 
(100 mL).  The reaction mixture was stirred at 58 ºC for 24 h.  The reaction mixture was 
evaporated, and the product was purified by chromatgr phy using ethyl acetate:hexane 
(40:60).  The product was isolated as a fluffy yellow solid (12 g, 57%), mp 166 ºC (lit15 
mp 166-167 ºC).  1H-NMR (400 MHz, DMSO-d6) δ 10.6 (s, 2H), 8.40-8.38 (m, 2H), 7.50 
(dd, 1H, J = 7.8, 1.8 Hz), 7.30 (dd, 1H, J = 7.8, 4.8 Hz), 6.63 (d, 2H, J = 1.8 Hz), 5.91-
5.89 (m, 2H), 5.65 (s, 2H), 5.40 (s, 1H); 13C-NMR (75 MHz, DMSO-d6) δ 149.3, 147.3, 
139.1, 135.4, 132.2, 123.2, 117.2, 107.0, 106.2, 41.3.   
 Methyl 3-(Di(1H-pyrrol-2-yl)methyl) benzoate (16).  Literature procedures were 
followed17.  A 250-mL, three-necked, round-bottomed flask, equipped with a magnetic 
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stirrer, a septum, a condenser and an argon inlet, was charged with methyl 3-
formylbenzoate (14) (2 g, 12.19 mmol) in freshly distilled pyrrole (37 mL).  The mixture 
was purged with argon for 15 min.  Trifluoroacetic a id (0.2 mL) was added, and the 
mixture stirred for 90 min at room temperature.  A saturated aqueous solution of 
NaHCO3 was added, and the organic materials were extracted with CH2Cl2 (3 × 75 mL).  
The CH2Cl2 extracts were combined, washed with saturated aqueous NaCl, dried 
(Na2SO4), filtered, and concentrated.  The residue was chromatographed using ethyl 
acetate:hexane (30:70) to afford 16 (1.9 g, 56%) as a yellow solid mp 125-127 ºC (lit.18 
mp 124-127 ºC).  1H-NMR (300 MHz, DMSO-d6) δ 10.6 (s, 2H), 7.87 (d, 2H, J = 9 Hz), 
7.31 (d, 2H, J = 9 Hz), 6.62 (s, 2H), 5.91 (m, 2H), 5.66 (s, 2H), 5.45 (s, 6H), 3.83 (s, 3H). 
5,10-Bis(3-pyridyl)-15,20-bis(3-methoxycarbonylphenyl)porphyrin (BPMP) (17).  A 
500-mL, round-bottomed flask, equipped with a magnetic stirrer and a reflux condenser, 
was charged with dipyrromethane 16 (0.8 g, 2.86 mmol) and nicotinaldehyde (13) (0.32 
g, 2.98 mmol) in acetic acid (350 mL).  The reaction mixture was refluxed for 5 h.  After 
cooling to room temperature, the reaction mixture was concentrated on a rotary 
evaporator.  A saturated aqueous solution of NaHCO3 was added to neutralize the acid, 
and the organic material was extracted with CH2 l2 (3 × 50 mL).  The organic extracts 
were washed with saturated aqueous NaCl, dried (Na2SO4), filtered, evaporated, and then 
chromatographed using 20-60% ethyl acetate in hexane.  Porphyrin-BPMP 17 was 
isolated as a purple solid (0.51 g, 24%), mp > 300 ºC.  IR (neat): 3329, 2951, 1731, 1685, 
1408, 1247, 802, 733, 712 cm-1; 1H-NMR (300 MHz, CDCl3) δ 9.46 (s, 2H), 9.06 (d, 2H, 
J = 4.8 Hz), 8.89-8.81 (m, 12H), 8.53-8.49 (m, H), 8.41 (d, 2H, J = 6 Hz), 7.86 (t, 2H, J = 
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7.8 Hz), 7.76 (t, 2H, J = 7.8 Hz), 3.96 (s, 6H), -2.82 (s, 2H);  13C-NMR (75 MHz, CDCl3) 
δ 154.0, 149.6, 142.4, 141.3, 138.1, 137.9, 135.2, 129.7, 127.4, 122.4, 119.9, 116.7, 52.8.  
5,10-Bis(3-pyridyl)-15,20-bis(3-carboxyphenyl)porphyrin (BPCP) (18).  The 
procedure of Goldberg19 was followed.  A 50-mL, round-bottomed flask, equipped with a 
magnetic stirrer and a reflux condenser, was charged with porphyrin-BPMP 17 (0.35 g, 
0.47 mmol) in THF (10 mL) and 6% methanolic KOH (4 mL).  The mixture was stirred 
at 35 ºC for 6 h.  After cooling to room temperature, the solvent was evaporated, water 
(75 mL) was added, and the mixture was acidified with 1M HCl to a pH of 4-6.  The 
porphyrin was extracted with ethyl acetate (3 × 100 mL).  The organic extracts were 
evaporated to dryness to afford prophyrin 18 (0.3 g, 95%) as brown-purple solid, mp > 
300 ºC.  IR (neat): 3330, 1699, 1582, 1297, 1248, 972, 796 cm-1; 1H-NMR (400 MHz, 
DMSO-d6) δ 13.28 (s, 2H), 9.36 (s, 2H), 9.03 (dd,  2H, J = 3.6, 0.9 Hz), 8.83 (s, 8H), 
8.67 (m, 4H), 8.47 (br s, 2H), 8.39 (d, 2H, J = 6 Hz), 7.95 (t, 2H, J = 5.7 Hz), 7.88 (t, 2H, 
J = 7.8 Hz), -2.98 (s, 2H); MS: m/z Calc. for C44H28N6O4 704.72, Found 704. 
BPMP Zn(II) Complex (19). A 100-mL, round-bottomed flask, equipped with a 
magnetic stirrer and a reflux condenser, was charged with porphyrin-BPMP 17 (0.15 g, 
0.20 mmol) in THF (50 mL), zinc acetate dihydrate (0.5 g) and methanol (3 mL).  The 
reaction mixture was refluxed at 60 ºC for 2 h.  The solvent was evaporated, and the 
product was washed with water, and dried under vacuum to afford porphyrin 19 as a 
purple solid (0.15 g, 92%), mp > 300 ºC.     
  BPCP Zn(II) Complex (20).  A 50-mL, round-bottomed flask, equipped with a 
magnetic stirrer and a reflux condenser, was charged with porphyrin 19 (0.10 g, 0.13 
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mmol) in THF (10 mL) and 6% methanolic KOH (2 mL).  The mixture was stirred at 35 
ºC for 6 h.  After cooling to room temperature, thesolvent was evaporated, water (10 mL) 
was added, and the mixture was acidified with 1M HCl to a pH of 6-7.  The porphyrin 
was extracted with ethyl acetate (3 × 50 mL).  The organic extracts were evaporated to 
dryness to afford porphyrin 20 (0.06 g, 66%) as purple solid mp > 300 ºC.  IR (neat): 
3400, 1728, 1436, 1284, 1224, 995, 794 cm-1; 1H-NMR (400 MHz, DMSO-d6) 9.29 (br s, 
4H), 8.96 (br s, 4H), 8.77-8.72 (dd, 8H, J = Hz), 8.62 (br s, 4H), 8.58 (m, 4H), 8.32-8.27 
(m, 4H), 7.82 (m, 4H); MS: m/z Calc. for C44H26N6O4Zn 767.39, Found 768.  
5,10,15,20-Tetra(3-pyridyl)porphyrin (TPP) (22).  A 500-mL, round-bottomed flask, 
equipped with a magnetic stirrer and a reflux condenser, was charged with 
dipyrromethane 15 (0.40 g, 1.79 mmol) and aldehyde 13 (0.20 g, 1.86 mmol) in acetic 
acid (250 mL).  The reaction mixture was refluxed for 5 h and, after cooling to room 
temperature, the reaction mixture was concentrated on a rotary evaporator.  A saturated 
aqueous solution of NaHCO3 was added to neutralize the acid, and the organic material 
was extracted with CH2Cl2 (3 × 50 mL).  The organic extracts were washed with 
saturated aqueous NaCl, dried (Na2SO4), filtered, evaporated, and then chromatographed 
using 20-60% ethyl acetate in dichloromethane.  Porphyrin 22 (0.19 g, 17%) was isolated 
as a purple solid, mp > 300 ºC.  IR (neat): 3307, 2952, 1668, 1406, 1183, 966 cm-1; 1H-
NMR (300 MHz, CDCl3) δ 9.48 (s, 4H), 9.07 (d, 4H, J = 3.9 Hz), 8.88 (s, 8H), 8.5 (d, 
4H, J = 6.6 Hz), 7.78 (t, 4H, J = 4.8 Hz), -2.80 (s, 2H); 13C-NMR (75 MHz, CDCl3) δ 




TPP Zn(II) Complex (23).  A 50-mL, round-bottomed flask, equipped with a magnetic 
stirrer and a reflux condenser, was charged with porphyrin 22 (0.10 g, 0.16 mmol), 
CHCl3 (15 mL), zinc acetate dihydrate (0.15 g) and methanol (3 mL).  The reaction 
mixture was stirred at room temperature overnight.  The solvent was evaporated, and the 
product was washed with water and dried under vacuum to afford porphyrin 23 (0.09 g, 
90%) as a purple solid, mp > 300 ºC.  IR (neat): 3042, 1669, 1471, 1184, 994, 788 cm-1; 
1H-NMR (400 MHz, DMSO-d6) δ 9.31 (s, 4H), 8.99 (dd,  4H, J = 4.8, 1.6 Hz), 8.77 (s, 
8H), 8.58 (br s, 4H), 7.85 (td,  4H, J = 7.6, 2 Hz); 13C-NMR (100 MHz, DMSO-d6 ) δ 
117.6, 122.8, 132.6, 135.2, 138.9, 141.2, 149.4, 150.1, 153.4.  
5,10-Bis(3-Pyridyl)-15,20-bis(4-hydroxyphenyl)porphyrin (BPHP) (24).  A 500-mL, 
round-bottomed flask, equipped with a magnetic stirrer and a reflux condenser was 
charged with dipyrromethane 15 (0.5 g, 2.24 mmol) and 4-hydroxybenzaldehyde (21) 
(0.27 g, 2.24 mmol) in acetic acid (250 mL).  The reaction mixture was refluxed for 5 h 
and, after cooling to room temperature, was concentrated on a rotary evaporator.  A 
saturated solution of NaHCO3 was added to neutralize the acid, and the organic material 
was extracted with CH2Cl2 (3 × 50 mL).  The organic extracts were washed with 
saturated aqueous NaCl, dried (Na2SO4), filtered, evaporated and then chromatographed 
using 20-60% ethyl acetate in dichloromethane.  Theporphyrin 24 (0.1 g, 13%) was 
obtained as a purple solid.  IR (neat): 3100, 1671, 1468, 1226, 966, 765, 711 cm-1; 1H-
NMR (400 MHz, DMSO-d6) δ 9.99 (s, 2H), 9.37 (s, 2H), 9.04 (d, 2H, J = 4.8 Hz), 8.92 
(d, 4H, J = 5.1 Hz), 8.81 (d, 4H, J = 5.1 Hz), 8.66 (d, 2H, J = 8 Hz), 8.01 (d, 4H, J = 7.2 




BPHP Zn(II) Complex (25).  A 100-mL, round-bottomed flask, equipped with a 
magnetic stirrer and a reflux condenser, was charged with porphyrin 24 (0.44 g, 0.67 
mmol), CH2Cl2 (25 mL), zinc acetate dihydrate (0.20 g) and methanol (3 mL).  The 
reaction mixture was stirred at room temperature ovrnight.  The solvent was evaporated, 
and the product was washed with water, and dried under vacuum to afford porphyrin 25 
(0.22 g, 91%) as a purple solid, mp > 300 ºC.  IR (neat): 3400, 1572, 1341, 1269, 994, 
793, 715 cm-1; 1H-NMR (300 MHz, DMSO-d6) δ  9.88 (s, 2H), 9.28 (s, 2H), 8.95 (d, 2H, 
J = 3.9 Hz), 8.86 (d, 4H, J = 4.8 Hz), 8.71 (d, 4H, J = 4.8 Hz), 8.58 (d, 2H, J = 7.2 Hz), 
7.96 (d, 4H, J = 8.1 Hz), 7.85 (t, 2H, J = 6.2 Hz), 7.18 (d, 4H, J = 8.1 Hz); MS: m/z Calc. 
for C42H26N6O2Zn 711.38, Found 712.  
5,10-Bis(3-pyridyl)-15,20-bis(4-nitrophenyl)porphyrin (BPNP) (27).  A 250-mL, 
round-bottomed flask, equipped with a magnetic stirrer and a reflux condenser, was 
charged with dipyrromethane 15 (0.2 g, 0.89 mmol), 4-nitrobenzaldehyde (26) (0.13 g, 
mmol) and a mixture of acetic acid and propionic acid (50 mL, 32:18).  The resulting 
solution was refluxed for 6 h, and after cooling to ro m temperature, the mixture was 
concentrated on a rotary evaporator.  A saturated solution of NaHCO3 was added to 
neutralize the acid, and the organic material was extracted with CH2Cl2 (3 × 25 mL).  The 
organic extracts were washed with saturated aqueous NaCl, dried (Na2SO4), filtered, 
evaporated, and then chromatographed using 20-60% ethyl acetate in dichloromethane.  
The porphyrin 27 (0.19 g, 61%) was isolated as a purple solid.  IR (neat): 3319, 2924, 
1689, 1514, 1344, 848, 799 cm-1; 1H-NMR (300 MHz, CDCl3) δ 9.43 (s, 2H), 9.07 (dd, 
2H, J = 5.1, 1.8 Hz), 8.86-8.80 (m, 8H), 8.64 (d, 4H, J = 9 Hz), 8.53 (d, 2H, J = 7.5 Hz), 
8.41 (d, 4H, J = 7.8 Hz), 7.78 (t, 2H, J = 6.9, 2.3 Hz), -2.84 (s, 2H).  
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 5,10-Bis(3-pyridyl)-15,20-bis(4-aminophenyl)porphyrin (BPAP) (28).  The Hatay 
procedure was followed.20  A 50-mL, round-bottomed flask, equipped with a magnetic 
stirrer and a reflux condenser, was charged with SnCl2.H2O (1.5 g) and a mixture of 
HCl/ether (1M, 20 mL).  Porphyrin 27 (0.1 g, 0.14 mmol) in CHCl3 (10 mL) was added, 
and the reaction mixture was stirred at room temperature for 8 h in the dark.  The 
resulting mixture was poured onto crushed ice and, when the ice melted, CHCl3 (50 mL) 
was added.  The organic layer was washed with water and then with 10% solution of 
NaOH and saturated aqueous NaCl.  The organic layerwas dried (Na2SO4), filtered, and 
concentrated to afford porphyrin 28 (0.083 g, 92%) as a purple solid.  1H-NMR (300 
MHz, CDCl3) δ 9.44 (s, 2H), 9.03 (d, 2H, J = 4.5 Hz),  8.97 (d, 4H, J = 4.5 Hz), 8.77 (d, 
4H, J = 4.5 Hz), 8.50 (d, 2H, J = 7.2 Hz), 7.97 (d, 4H, J = 7.8 Hz), 7.74 (t, 2H, J = 7.5 
Hz), 7.08 (d, 4H, J =  7.8 Hz), -2.78 (s, 2H).  
BPAP Zn(II) Complex (29).  A 50-mL, round-bottomed flask, equipped with a magnetic 
stirrer and a reflux condenser, was charged with porphyrin 28 (0.20 g, 0.31 mmol), zinc 
acetate dihydrate (0.20 g) and methanol (3 mL).  The reaction mixture was stirred at 
room temperature overnight.  The solvent was evaporated, and the product was washed 
with water, and dried under vacuum to afford porphyin 29 (0.2 g, 75%) as a green solid, 
mp > 300 ºC.  IR (neat): 3300, 1504, 1392, 831, 695 cm-1; 1H-NMR (400 MHz, DMSO-
d6) δ 9.25 (s, 2H), 8.93 (s, 2H), 8.89 (d, 4H, J = 4.8 Hz), 8.66 (d, 4H, J = 4.8 Hz), 8.55 (d, 
2H, J = 6.8 Hz), 7.83-7.77 (m, 6H), 6.94 (d, 2H, J = 8.4 Hz), 5.46 (s, 2H); 13C-NMR (100 
MHz, DMSO-d6) δ 153.5, 150.9, 149.5, 148.8, 141.2, 139.3, 135.9, 133, 31.4, 130.4, 
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PHENYLACETYLENE MACROCYCLES  
Introduction 
 In recent years, shape persistent arylene ethynylene  macrocycles have been 
extensively investigated because of their potential as functional materials and host-guest 
systems, aggregation/adsorption phenomena, including solution state aggregation, liquid 
crystallinity and surface adsorption (Figure 5.1).1  Their rigid backbones give large 
molecular surfaces that organize into ordered structu es.  These large supramolecular 
building blocks generate π-stacked structures in solution, noncollapsable nanoporous 




Figure 5.1.  Shape persistent arylene ethynylene macrocycles. 
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have a regular repeating unit with few degrees of cnformational freedom.  The 
ethynylene functional group is an attractive building block for these structures as a result 
of the potential for extended conjugation, simple linear geometry, pure carbon 
composition, and accessibility through a wide range of synthesis.2  Moreover, the ability 
of the acetylene linkage to transmit electronic perturbation within conjugated systems 
makes them useful components in the construction of m lecular wires, conjugated 
dendrimers and optical systems.3-5  
 Such molecules have been synthesized by homocoupling (e.g. Glaser reaction)6 
and cross-coupling reactions.  Two types of monomers are required, whether for 
homocoupling or cross-coupling reactions for cyclooligomerization (Figure 5.2).7  A 
difunctionalized monomer AB (which has two different functional groups A and B on the 
same molecule, and A can only react with B) is representative of cross-coupling 
cyclooligomerization, while a difunctionalized AA monomer (two identical functional 
groups A on the same molecule, and A can react with B) is representative of 
homocoupling cyclooligomerization.  Ring closure occurs mainly by intramolecular 
interaction between the terminal functional groups.  The main disadvantage of these 
coupling-based approaches is the formation of higher oligomers (overshooting) which is 

















Figure 5.2.  Reaction pathways for oligomerization and cyclohexamer formation from    
                    A2- and B2-type monomers.  AMA = A monomer A (9) and BMB = B      
                    monomer B (11). 
 
 Our aim in this project was to prepare a phenylacetylene cyclic structure with the 
functional group NH2 in its central cavity.  This functional group is able to complex with 
metals.  The promise of these compounds is that they can be used for purification of 








 Starting from aniline 3, it was possible to obtain 4-iodoaniline (4) (51%) by 
iodination of aniline8 via reaction with iodine and NaHCO3 in aqueous solution.  
Acetylation of compound 4 with acetic anhydride formed the protected amine compound 
5 (87%).  Sonogashira coupling reaction9 of 5 using Pd(PPh3)4, CuI and 1-hexyne 
produced compound 6 (84%).10  The corresponding alkane derivative 7 (84%) was 
obtained by reduction of the alkyne 6 using triethylsilane (TES) and Pd/C 10% in 
methanol.11  Hydrolysis of the amide group in 7 using 70% H2SO4 afforded the amine 8  
(98%).  Iodination
8 of 8 provided the diiodo derivative 9 (70%).  Sonogashira coupling9 
with 2 equivalents of trimethylsilyl acetylene produced disilylated compound 10 (73%).  
Compound 11 was obtained (79%) by desilylation of 10 using K2CO3 in methanol.
12  For 
cyclization to form the phenylacetylene compound 12, compounds 9 and 11 should react 
under Sonogashira coupling conditions (Figure 5.3). 
 
Results and Discussion 
  All compounds in Figure 5.2 were obtained in high yields except for the last step. 
Chromatography of the reaction mixture showed that overshooting occurred and gave by-











 Chemicals were purchased from commercial sources and, unless specified, were 
used without further purification.  Sonogashira coupling reactions were performed under 
argon by using dry THF and triethylamine.  Reactions were monitored by TLC on hard 
layer silica gel GF plates (Analtech No. 21521) using UV detection.  Column 
chromatography was performed on silica gel (Davisil®, grade 62, 60-200 mesh).  Both 
1H-NMR and 13C-NMR spectra were acquired in CDCl3 or DMSO-d6 using a Varian 
Inova 300 MHz or a 400 MHz NMR spectrometer.  Chemical shifts (δ) are expressed in 
ppm relative to residual chloroform (1H: 7.26 ppm, 13C: 77.16 ppm) or to TMS (0.0 ppm).  
Fourier Transform Infrared (FT-IR) measurements were performed on a Varian 800 FT-
IR spectrometer.  UV-VIS spectra were recorded on Cary 5000 UV-VIS-NIR 
spectrophotometer.   
N-(4-Iodophenyl)acetamide (5).  A 250-mL, round-bottomed flask, equipped with a 
magnetic stirrer and a reflux condenser, was charged with acetic anhydride (20 mL) and 
4-iodoaniline (4) (1 g, 4.56 mmol).  The mixture was heated in a water bath for 30 min.  
The hot solution was poured onto crushed ice, filtered, washed with water and dried 
under vacuum to afford 5 (1.05 g, 87%) as a yellow-white solid, mp 184 (lit.13 181-185 
ºC).  
N-(4-n-Hexyn-1-yl)phenyl)acetamide (6).  ).  A 250-mL, three-necked, round-bottomed 
flask, equipped with a magnetic stirrer, a septum, a condenser and a nitrogen inlet was 
charged with N-(4-iodophenyl)acetamide (5) (0.5 g, 1.90 mmol), triethylamine (10 mL) 
and dry THF (10 mL).  The resulting solution was purged with argon for 20 min.   
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Pd(PPh3)4 (0.08 g, 0.07 mmol), CuI (0.032 mg, 0.16  mmol) and 1-hexyne (0.17 g, 2.07 
mmol) were then added and the reaction mixture was heated at 65 ºC for 24 h.  After 
cooling to room temperature the reaction mixture was filtered through Celite 545®, and 
the solvent was evaporated.  The crude material was chromatographed using ethyl 
acetate:hexane (35:65) to afford 6 (0.35 g, 84%) as a yellow solid, mp 120-122 ºC.  IR 
(neat): 3301, 1667, 1535, 832 cm-1; 1H-NMR (400 MHz, CDCl3) δ 7.39 (d, 2H, J = 8.0 
Hz), 7.31 (d, 2H, J = 8.0 Hz), 2.36 (t, 2H, J = 7.6 Hz), 2.13 (s, 3H), 1.57-1.51 (septet, 2H, 
J = 7.6, 7.2 Hz), 1.47-1.41 (sextet, 2H), 0.91 (t, 3H, J = 7.2 Hz); 13C-NMR (100 MHz, 
CDCl3) δ 168.5, 137.3, 132.4, 120.0, 119.5, 90.2, 80.3, 31.0, 24.8, 22.2, 19.3, 13.8. 
N-(4-n-Hexylphenyl)acetamide (7). A 100-mL, three-necked, round-bottomed flask, 
equipped with a magnetic stirrer, a septum, and a ¼ argon filled balloon as an outlet was 
charged with compound 6 (0.5 g, 2.31 mmol), MeOH (25 mL) and 10% Pd/C (0.25 g).  
Triethylsilane (7 mL) was added dropwise and the resulting mixture was stirred at room 
temperature for 4 h.  The reaction mixture was filtered through Celite 545®, and the 
solvent was evaporated to afford 7 (0.43 g, 84%) as a white solid, mp 89-90 ºC (lit.13 mp 
91 ºC).  IR (neat): 3284, 2853, 1660, 840 cm-1; 1H-NMR (300 MHz, CDCl3) δ 7.35 (d, 
2H, J = 8.4 Hz), 7.19 (s, 1H), 7.10 (d, 2H, J = 8.4 Hz), 2.53 (t, 2H, J = 7.8 Hz), 2.13 (s, 
3H), 1.55 (m, 2H), 1.26 (m, 6H), 0.85 (t, 3H, J = 6.6 Hz); 13C-NMR (57 MHz, CDCl3) δ 
168.0, 139.3, 135.6, 129.0, 120.1, 35.5, 31.9, 31.6, 29.1, 24.7, 22.8, 14.3. 
4-n-Hexylaniline (8).  A 250-mL, round-bottomed flask, equipped with a magnetic 
stirrer and a reflux condenser, was charged with7 (1.2 g, 5.44 mmol) and 70% H2SO4 (75 
mL).  The reaction mixture was heated overnight at 100 ºC.  After cooling to room  
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temperature the mixture was neutralized with 70% aqueous NaOH and was extracted 
with CH2Cl2 (3 × 75 mL).  The organic extracts were washed with saturated aqueous 
NaCl, dried (Na2SO4), filtered, and concentrated to produce 8 (0.95 g, 98%) as a brown 
oil, (lit.14 bp 140 ºC).  IR (neat): 3427-3353, 1623, 816 cm-1; 1H-NMR (300 MHz, CDCl3) 
δ 6.97 (d, 2H, J = 8.1 Hz), 6.64 (d, 2H, J = 8.1 Hz), 3.53 (s, 2H), 2.51 (t, 2H, J = 7.6 Hz), 
1.56-1.54 (m, 2H), 1.30 (m, 6H), 0.9 (t, 3H, J = 7.1 Hz); 13C-NMR (75 MHz, CDCl3) δ 
145.6, 137.5, 128.9, 115.0, 35.7, 31.8, 31.2, 28.9, 22.7, 14.1. 
4-n-Hexyl-2,6-diiodoaniline (9).  A 250-mL, round-bottomed flask, equipped with a 
magnetic stirrer was charged with 4-n-hexylaniline (8) (0.95 g, 5.32 mmol), NaHCO3 
(3.0 g) and water (45 mL).  The reaction mixture was cooled to 10-12 ºC (ice bath) and 
iodine (5 g) was added in small portions.  After complete addition, the reaction mixture 
was stirred for 4 h.  A saturated solution of NaHSO3 (75 mL) was added, and the product 
was extracted with CH2Cl2 (3 × 50 mL).  The organic extracts were washed with 
saturated aqueous NaCl, dried (Na2SO4), filtered, and concentrated to afford 9 (1.32 g, 
69%) as a white solid, mp 85-87 ºC.  IR (neat): 3411, 1610, 865, 703 cm-1; 1H-NMR (400 
MHz, CDCl3) δ 7.43 (s, 2H), 4.43 (s, 2H), 2.38 (t, 2H, J = 7.8 Hz), 1.53-1.45 (m, 2H), 
1.28-1.26 (m, 6H), 0.85 (t, 3H, J = 7.2 Hz);  13C-NMR (100 MHz, CDCl3) δ 144.1, 139.3, 
136.5, 81.7, 34.1, 31.8, 31.6, 28.9, 22.7, 14.3; MS: m/z Calc. for C12H17I2N 429.26, found 
431. 
4-n-Hexyl-2,6-bis[(trimethylsilyl)ethynyl]aniline (10).  A 250-mL, three-necked, 
round-bottomed flask, equipped with a magnetic stirrer, a septum, a condenser and a 
nitrogen inlet was charged with compound 9 (0.4 g, 0.93 mmol), triethylamine (10 mL)  
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and dry THF (10 mL).  The resulting solution was purged with argon for 20 min.  
Pd(PPh3)4 (0.08 g, 0.07 mmol), CuI (0.032 mg, 0.16  mmol) and trimethylsilylacetylene 
(0.83 g, 8.45 mmol) were then added and the reaction mixture was heated at 65 ºC for 24 
h.  After cooling to room temperature the reaction mixture was filtered through Celite 
545®, and the solvent was evaporated.  The crude product was chromatographed using 
ethyl acetate:hexane (20:80) to afford 10 (0.25 g, 73%) as a white solid mp 60-61 ºC.  IR 
(neat): 3489, 3387, 2145, 1612, 1249, 843, 759 cm-1; 1H-NMR (400 MHz, acetone-d6) δ 
6.84 (s, 2H), 4.79 (s, 2H), 2.19 (t, 3H, J = 7.6 Hz), 1.30-1.27 (m, 2H), 1.05 (m, 6H), 0.62 
(t, 3H, J = 6.6 Hz), 0.01 (s, 18H); 13C-NMR (100 MHz, acetone-d6) δ 149.2, 133.2, 
131.3, 107.5, 102.3, 99.8, 34.9, 32.2, 23.0, 14.2, 0.27. 
2,6-Diethynyl-4-hexylaniline (11). A 100-mL, round-bottomed flask, equipped with a 
magnetic stirrer was charged with compound 10 (0.24 g, mmol), K2CO3 (0.30 g) and 
methanol (25 mL).  The reaction mixture was stirred overnight at room temperature.  The 
solvent was removed under vacuum, water (25 mL) wasadded and the product was 
extracted with CH2Cl2 (3 × 50 mL).  The organic extracts were washed with saturated 
aqueous NaCl, dried (Na2SO4), filtered, and evaporated to afford 11 (0.12 g, 79%) as a 
yellow solid, mp 74-76 ºC.  IR (neat): 3484, 3384, 2098, 1613, 1465 cm-1; 1H-NMR (400 
MHz, CDCl3) δ 7.09 (s, 2H), 4.66 (s, 2H), 3.33 (s, 2H), 2.38 (t, 3H, J = 7.6 Hz), 1.52-
1.44 (m, 2H), 1.23 (m, 6H), 0.82 (t, 3H, J = 7.2 Hz); 13C-NMR (100 MHz, CDCl3) δ 
148.5, 133.5, 131.7, 106.3, 82.7, 80.5, 34.7, 31.5, 28.9, 22.7, 14.3; MS: m/z Calc. for 
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